Medications for human use with a single active ingredient starting with the letter O-R.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre O-R.

Updated | Mise à jour : 2021-07-04
∙ Product name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercialisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN
Monograph | Monographie
OCALIVA;
obeticholic acid 10 mg;
2017-05-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
INTERCEPT PHARMACEUTICALS INC.
DIN: 02463148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95105
OCALIVA;
obeticholic acid 5 mg;
2017-05-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
INTERCEPT PHARMACEUTICALS INC.
DIN: 02463121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95104
GAZYVA;
obinutuzumab 25 mg / ml;
2014-11-28;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02434806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91910
OCREVUS;
ocrelizumab 30 mg / ml;
2017-09-21;
Intravenous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02467224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95561
TEINT IDOLE ULTRA WEAR;
octinoxate 3 % / w/w;
2012-04-13;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02379228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86510
TEINT LIFT ANTI-RIDES FPS 20 SPF 20;
octinoxate 4 % / w/w;
2005-01-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02259338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74459
PROTECTIVE LIP CONDITIONER;
octinoxate 4.9 % / w/w;
2015-11-09;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02430762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91520
TRUE MATCH LUMI;
octinoxate 7 % / w/w;
2012-05-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02387018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87257
OCTINOXATE LOTION SPF 18;
octinoxate 7 % / w/w;
2014-07-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
DIN: 02407191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89191
BEYOND COLOR LIPSTICK SPF 15;
octinoxate 7.5 % / w/w;
2015-07-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02435020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91931
BEYOND COLOR LIP CONDITIONER SPF 15;
octinoxate 7.5 % / w/w;
2015-07-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02435039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91932
LISE WATIER CC CREME FPS 25 SPF;
octinoxate 7.5 % / w/w;
2017-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02457458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94450
SANDOSTATIN LAR;
octreotide (octreotide acetate) 10 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02239323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62792
SANDOSTATIN;
octreotide (octreotide acetate) 100 mcg / ml;
1989-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00839205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9916
OCTREOTIDE ACETATE OMEGA;
octreotide (octreotide acetate) 100 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02248640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72997
SANDOSTATIN LAR;
octreotide (octreotide acetate) 20 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02239324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62793
SANDOSTATIN;
octreotide (octreotide acetate) 200 mcg / ml;
1996-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02049392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19627
OCTREOTIDE ACETATE OMEGA;
octreotide (octreotide acetate) 200 mcg / ml;
2004-03-11;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02248642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72999
SANDOSTATIN LAR;
octreotide (octreotide acetate) 30 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02239325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62794
SANDOSTATIN;
octreotide (octreotide acetate) 50 mcg / ml;
1989-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00839191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9915
OCTREOTIDE ACETATE OMEGA;
octreotide (octreotide acetate) 50 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02248639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72996
OCTREOTIDE ACETATE OMEGA;
octreotide (octreotide acetate) 500 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02248641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72998
KESIMPTA;
ofatumumab 20 mg / 0.4 ml;
2021-04-08;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02511355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100057
OCUFLOX;
ofloxacin 0.3 %;
1995-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ALLERGAN INC
DIN: 02143291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18491
ZYPREXA INTRAMUSCULAR;
olanzapine (olanzapine tartrate) 10 mg / vial;
2004-01-12;
Intramuscular;
Powder For Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02247099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71336
OLANZAPINE FOR INJECTION;
olanzapine (olanzapine tartrate) 10 mg / vial;
2014-07-22;
Intramuscular;
Powder For Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02416522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90112
ZYPREXA – 10MG;
olanzapine 10 mg;
1996-11-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02229285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43533
ZYPREXA ZYDIS;
olanzapine 10 mg;
2001-03-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02243087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66954
TEVA-OLANZAPINE;
olanzapine 10 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02276747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76242
APO-OLANZAPINE;
olanzapine 10 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02281821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76748
PMS-OLANZAPINE;
olanzapine 10 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78850
PMS-OLANZAPINE ODT;
olanzapine 10 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78853
SANDOZ OLANZAPINE;
olanzapine 10 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79602
OLANZAPINE;
olanzapine 10 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02311992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79752
SANDOZ OLANZAPINE ODT;
olanzapine 10 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81319
RIVA-OLANZAPINE;
olanzapine 10 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02337150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82276
OLANZAPINE ODT;
olanzapine 10 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02338653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82432
OLANZAPINE ODT;
olanzapine 10 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02343673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82911
APO-OLANZAPINE ODT;
olanzapine 10 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02360624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84559
OLANZAPINE;
olanzapine 10 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02372843
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85793
OLANZAPINE;
olanzapine 10 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87150
JAMP OLANZAPINE ODT;
olanzapine 10 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89132
MINT-OLANZAPINE;
olanzapine 10 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02410184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89484
RAN-OLANZAPINE ODT;
olanzapine 10 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02414104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89877
JAMP OLANZAPINE FC;
olanzapine 10 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90191
MINT-OLANZAPINE ODT;
olanzapine 10 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02436973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92129
AURO-OLANZAPINE ODT;
olanzapine 10 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02448734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93445
AG-OLANZAPINE FC;
olanzapine 10 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02487632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97778
ZYPREXA 15MG;
olanzapine 15 mg;
2002-06-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02238850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62290
ZYPREXA ZYDIS;
olanzapine 15 mg;
2004-01-09;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02243088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66955
TEVA-OLANZAPINE;
olanzapine 15 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02276755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76243
APO-OLANZAPINE;
olanzapine 15 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02281848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76749
PMS-OLANZAPINE;
olanzapine 15 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78851
PMS-OLANZAPINE ODT;
olanzapine 15 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78854
SANDOZ OLANZAPINE;
olanzapine 15 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79603
OLANZAPINE;
olanzapine 15 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79753
SANDOZ OLANZAPINE ODT;
olanzapine 15 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81320
RIVA-OLANZAPINE;
olanzapine 15 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02337169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82277
OLANZAPINE ODT;
olanzapine 15 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02338661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82433
OLANZAPINE ODT;
olanzapine 15 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02343681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82912
OLANZAPINE ODT;
olanzapine 15 mg;
2011-10-07;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02352990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83822
APO-OLANZAPINE ODT;
olanzapine 15 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02360632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84560
OLANZAPINE;
olanzapine 15 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02372851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85794
OLANZAPINE;
olanzapine 15 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87151
JAMP OLANZAPINE ODT;
olanzapine 15 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89133
MINT-OLANZAPINE;
olanzapine 15 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02410192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89485
RAN-OLANZAPINE ODT;
olanzapine 15 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02414112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89878
JAMP OLANZAPINE FC;
olanzapine 15 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90192
MINT-OLANZAPINE ODT;
olanzapine 15 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02436981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92130
AURO-OLANZAPINE ODT;
olanzapine 15 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02448742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93446
ZYPREXA;
olanzapine 2.5 mg;
1997-12-08;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02229250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43530
TEVA-OLANZAPINE;
olanzapine 2.5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02276712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76239
APO-OLANZAPINE;
olanzapine 2.5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02281791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76745
PMS-OLANZAPINE;
olanzapine 2.5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78844
SANDOZ OLANZAPINE;
olanzapine 2.5 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79599
OLANZAPINE;
olanzapine 2.5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02311968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79749
RIVA-OLANZAPINE;
olanzapine 2.5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02337126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82273
OLANZAPINE;
olanzapine 2.5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02372819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85790
OLANZAPINE;
olanzapine 2.5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87147
MINT-OLANZAPINE;
olanzapine 2.5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02410141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89481
JAMP OLANZAPINE FC;
olanzapine 2.5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90188
AG-OLANZAPINE FC;
olanzapine 2.5 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02487608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97775
ZYPREXA 20MG;
olanzapine 20 mg;
2007-04-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02238851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62291
ZYPREXA ZYDIS;
olanzapine 20 mg;
2007-01-02;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02243089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66956
SANDOZ OLANZAPINE ODT;
olanzapine 20 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81321
APO-OLANZAPINE;
olanzapine 20 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02333015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81866
OLANZAPINE ODT;
olanzapine 20 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02343703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82913
TEVA-OLANZAPINE;
olanzapine 20 mg;
2011-04-28;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02359707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84470
APO-OLANZAPINE ODT;
olanzapine 20 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02360640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84561
JAMP OLANZAPINE ODT;
olanzapine 20 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89134
RAN-OLANZAPINE ODT;
olanzapine 20 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02414120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89879
JAMP OLANZAPINE FC;
olanzapine 20 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90193
OLANZAPINE;
olanzapine 20 mg;
2014-06-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02421704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90636
OLANZAPINE ODT;
olanzapine 20 mg;
2014-06-10;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02425114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90977
AURO-OLANZAPINE ODT;
olanzapine 20 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02448750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93447
ZYPREXA – 5MG;
olanzapine 5 mg;
1996-11-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02229269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43531
ZYPREXA ZYDIS;
olanzapine 5 mg;
2001-03-06;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02243086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66953
TEVA-OLANZAPINE;
olanzapine 5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02276720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76240
APO-OLANZAPINE;
olanzapine 5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02281805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76746
PMS-OLANZAPINE;
olanzapine 5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78848
PMS-OLANZAPINE ODT;
olanzapine 5 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78852
SANDOZ OLANZAPINE;
olanzapine 5 mg;
2009-12-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79600
OLANZAPINE;
olanzapine 5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02311976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79750
SANDOZ OLANZAPINE ODT;
olanzapine 5 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81318
RIVA-OLANZAPINE;
olanzapine 5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02337134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82274
OLANZAPINE ODT;
olanzapine 5 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02338645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82431
OLANZAPINE ODT;
olanzapine 5 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02343665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82910
APO-OLANZAPINE ODT;
olanzapine 5 mg;
2011-11-16;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02360616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84558
OLANZAPINE;
olanzapine 5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02372827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85791
OLANZAPINE;
olanzapine 5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87148
JAMP OLANZAPINE ODT;
olanzapine 5 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89131
MINT-OLANZAPINE;
olanzapine 5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02410168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89482
RAN-OLANZAPINE ODT;
olanzapine 5 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02414090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89876
JAMP OLANZAPINE FC;
olanzapine 5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90189
MINT-OLANZAPINE ODT;
olanzapine 5 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02436965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92128
AURO-OLANZAPINE ODT;
olanzapine 5 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02448726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93444
AG-OLANZAPINE FC;
olanzapine 5 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02487616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97776
ZYPREXA;
olanzapine 7.5 mg;
1996-11-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
DIN: 02229277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43532
TEVA-OLANZAPINE;
olanzapine 7.5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02276739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76241
APO-OLANZAPINE;
olanzapine 7.5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02281813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76747
PMS-OLANZAPINE;
olanzapine 7.5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02303167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78849
SANDOZ OLANZAPINE;
olanzapine 7.5 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79601
OLANZAPINE;
olanzapine 7.5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02311984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79751
RIVA-OLANZAPINE;
olanzapine 7.5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02337142
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82275
OLANZAPINE;
olanzapine 7.5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02372835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85792
OLANZAPINE;
olanzapine 7.5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87149
MINT-OLANZAPINE;
olanzapine 7.5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02410176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89483
JAMP OLANZAPINE FC;
olanzapine 7.5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02417278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90190
LYNPARZA;
olaparib 100 mg;
2018-05-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02475200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96554
LYNPARZA;
olaparib 150 mg;
2018-05-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02475219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96555
OLMETEC;
olmesartan medoxomil 20 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02318660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80414
ACT OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02442191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92655
SANDOZ OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02443414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92810
AURO-OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02443864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92863
APO-OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-05-31;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02453452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94000
ACH-OLMESARTAN;
olmesartan medoxomil 20 mg;
2020-05-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02456311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94319
PMS-OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-06-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02461307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94881
JAMP-OLMESARTAN;
olmesartan medoxomil 20 mg;
2017-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02461641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94931
GLN-OLMESARTAN;
olmesartan medoxomil 20 mg;
2019-03-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02469812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95870
OLMESARTAN;
olmesartan medoxomil 20 mg;
2020-02-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02481057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97140
OLMESARTAN;
olmesartan medoxomil 20 mg;
2019-07-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02488744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97883
NRA-OLMESARTAN;
olmesartan medoxomil 20 mg;
2020-11-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NORA PHARMA INC
DIN: 02499258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98899
OLMETEC;
olmesartan medoxomil 40 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02318679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80415
ACT OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02442205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92656
SANDOZ OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02443422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92811
AURO-OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02443872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92864
APO-OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02453460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94001
ACH-OLMESARTAN;
olmesartan medoxomil 40 mg;
2020-05-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02456338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94320
PMS-OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-06-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02461315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94882
JAMP-OLMESARTAN;
olmesartan medoxomil 40 mg;
2017-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02461668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94932
GLN-OLMESARTAN;
olmesartan medoxomil 40 mg;
2019-03-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02469820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95871
OLMESARTAN;
olmesartan medoxomil 40 mg;
2020-02-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02481065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97141
OLMESARTAN;
olmesartan medoxomil 40 mg;
2019-07-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02488752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97884
NRA-OLMESARTAN;
olmesartan medoxomil 40 mg;
2020-11-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NORA PHARMA INC
DIN: 02499266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98900
APO-OLOPATADINE;
olopatadine (olopatadine hydrochloride) 0.1 %;
2013-07-26;
Ophthalmic;
Solution;
04:00.00 – ANTIHISTAMINE DRUGS;
Prescription;
APOTEX INC
DIN: 02305054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79042
PATANOL;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
1998-02-09;
Ophthalmic;
Liquid;
04:00.00 – ANTIHISTAMINE DRUGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02233143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53275
SANDOZ OLOPATADINE;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2013-02-04;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02358913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84395
ACT OLOPATADINE 0.1%;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2013-12-06;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02403986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88874
MINT-OLOPATADINE;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2014-07-29;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02422727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90739
JAMP-OLOPATADINE;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2017-10-06;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02458411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94555
PATADAY;
olopatadine (olopatadine hydrochloride) 0.2 % / w/v;
2011-04-14;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02362171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84721
SANDOZ OLOPATADINE 0.2%;
olopatadine (olopatadine hydrochloride) 0.2 % / w/v;
2014-02-24;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02420171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90478
PAZEO;
olopatadine (olopatadine hydrochloride) 0.7 % / w/v;
2018-03-12;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02458551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94571
DIPENTUM;
olsalazine sodium 250 mg;
1995-12-31;
Oral;
Capsule;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02063808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17893
XOLAIR;
omalizumab 150 mg / ml;
2017-07-06;
Subcutaneous;
Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02459795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94712
XOLAIR;
omalizumab 150 mg / vial;
2005-02-03;
Subcutaneous;
Powder For Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02260565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74602
XOLAIR;
omalizumab 75 mg / 0.5 ml;
2017-06-28;
Subcutaneous;
Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02459787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94711
TEVA-OMEPRAZOLE;
omeprazole (omeprazole magnesium) 10 mg;
2008-09-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02295407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78071
LOSEC;
omeprazole (omeprazole magnesium) 20 mg;
1996-12-31;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02190915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19716
TEVA-OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2008-09-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02295415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78072
RIVA-OMEPRAZOLE DR;
omeprazole (omeprazole magnesium) 20 mg;
2013-07-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02402416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88725
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS;
omeprazole (omeprazole magnesium) 20 mg;
2013-12-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02416549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90114
JAMP-OMEPRAZOLE DR;
omeprazole (omeprazole magnesium) 20 mg;
2014-02-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02420198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90479
OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2015-11-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Otc;
LABORATOIRE RIVA INC.
DIN: 02439018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92337
NAT-OMEPRAZOLE DR;
omeprazole (omeprazole magnesium) 20 mg;
2015-07-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92395
PRIVA-OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2016-09-07;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02449919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93578
BIO-OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2016-09-07;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02449927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93579
OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2020-03-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02490692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98075
NRA-OMEPRAZOLE;
omeprazole (omeprazole magnesium) 20 mg;
2020-12-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02501880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99149
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS;
omeprazole (omeprazole magnesium) 20 mg;
2021-03-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02504294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99372
SANDOZ OMEPRAZOLE;
omeprazole 10 mg;
2007-09-14;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02296438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78175
LOSEC;
omeprazole 20 mg;
1989-12-31;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 00846503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9823
APO-OMEPRAZOLE;
omeprazole 20 mg;
2004-01-28;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02245058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69062
SANDOZ OMEPRAZOLE;
omeprazole 20 mg;
2007-09-14;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02296446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78176
PMS-OMEPRAZOLE;
omeprazole 20 mg;
2009-03-13;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02320851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80626
OMEPRAZOLE;
omeprazole 20 mg;
2010-02-05;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02339927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82550
OMEPRAZOLE;
omeprazole 20 mg;
2010-06-16;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02348691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83404
OMEPRAZOLE-20;
omeprazole 20 mg;
2013-10-23;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89644
HEARTBURN CONTROL;
omeprazole 20 mg;
2015-03-12;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Otc;
APOTEX INC
DIN: 02435683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92002
BOTOX;
onabotulinumtoxina 100 unit / vial;
1992-12-31;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
ALLERGAN INC
DIN: 01981501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13476
BOTOX COSMETIC;
onabotulinumtoxina 100 unit / vial;
2001-05-07;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
ALLERGAN INC
DIN: 02243721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67653
ZOLGENSMA;
onasemnogene abeparvovec 20000000000000 vg / ml;
2021-02-04;
Intravenous;
Solution;
26:00.00 – CELLULAR AND GENE THERAPY;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02509695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99897
ZOFRAN;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
1999-08-01;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02213745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43137
ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2012-06-28;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02274418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75986
ONDANSETRON INJECTION USP -(PRESERVATIVE FREE);
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2006-04-19;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76501
ONDANSETRON INJECTION USP -(WITH PRESERVATIVE);
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2006-04-19;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76502
ONDANSETRON INJECTION, USP;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2013-05-09;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02390019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87549
ONDANSETRON INJECTION, USP;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2013-05-09;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02390051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87552
JAMP-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2014-03-14;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02420414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90500
JAMP-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2014-03-14;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02420422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90501
ONDANSETRON INJECTION USP;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2021-04-28;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
STERIMAX INC
DIN: 02462257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94995
ONDANSETRON INJECTION USP;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2018-05-22;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
STERIMAX INC
DIN: 02464578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95270
ONDANSETRON INJECTION USP;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2021-05-10;
Intravenous;
Solution;
56:22.00 – ANTIEMETICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02503905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99334
ZOFRAN;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
1998-03-30;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02213567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43116
PMS-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02258188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74341
SANDOZ ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02274310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75976
APO-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-11-16;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02288184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77362
ACT ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2009-06-29;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02296349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78168
MYLAN-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2007-07-20;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02297868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78319
NAT-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2015-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02417839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90245
ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2014-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02421402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90603
CCP-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2017-07-24;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02458810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94596
ACCEL-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2019-09-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ACCEL PHARMA INC
DIN: 02478927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96963
ZOFRAN;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
1996-11-13;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02229639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47565
APO-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
2008-03-04;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02291967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77733
JAMP ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
2020-04-22;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02490617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98068
ZOFRAN;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
1997-04-14;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02213575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43117
PMS-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02258196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74342
SANDOZ ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02274329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75977
APO-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-11-16;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02288192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77363
ACT ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2009-06-29;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02296357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78169
MYLAN-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2007-07-20;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02297876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78320
ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2009-06-25;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02325160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81057
NAT-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2015-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02417847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90246
ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2014-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02421410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90604
CCP-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2017-07-24;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02458802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94595
ACCEL-ONDANSETRON;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2019-09-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ACCEL PHARMA INC
DIN: 02478935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96964
MINT-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 4 mg;
2008-04-23;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02305259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79079
JAMP-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 4 mg;
2008-09-26;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02313685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79919
MAR-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 4 mg;
2012-12-21;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85687
MINT-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 8 mg;
2008-04-23;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02305267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79080
JAMP-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 8 mg;
2008-09-26;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02313693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79920
MAR-ONDANSETRON;
ondansetron (ondansetron hydrochloride) 8 mg;
2012-12-21;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85688
ZOFRAN ODT;
ondansetron 4 mg;
1999-03-31;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02239372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62841
ONDISSOLVE ODF;
ondansetron 4 mg;
2013-02-08;
Oral;
Film, Soluble;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TAKEDA CANADA INC
DIN: 02389983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87545
ATHENA-ONDANSETRON ODT;
ondansetron 4 mg;
2015-11-23;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ATHENA PHARMACEUTIQUES SAS
DIN: 02444674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92979
ONDANSETRON ODT;
ondansetron 4 mg;
2019-05-15;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02481723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97221
MINT-ONDANSETRON ODT;
ondansetron 4 mg;
2019-10-16;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02487330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97750
ZOFRAN ODT;
ondansetron 8 mg;
1999-03-31;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02239373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62842
ONDISSOLVE ODF;
ondansetron 8 mg;
2013-02-08;
Oral;
Film, Soluble;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TAKEDA CANADA INC
DIN: 02389991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87546
ATHENA-ONDANSETRON ODT;
ondansetron 8 mg;
2015-11-23;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ATHENA PHARMACEUTIQUES SAS
DIN: 02444682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92980
ONDANSETRON ODT;
ondansetron 8 mg;
2019-05-15;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02481731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97222
MINT-ONDANSETRON ODT;
ondansetron 8 mg;
2019-10-16;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02487349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97751
XENICAL;
orlistat 120 mg;
1999-06-03;
Oral;
Capsule;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02240325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63865
ORFENACE TABLET 100MG;
orphenadrine citrate 100 mg;
1994-12-31;
Oral;
Tablet;
12:20.92 – MISCELLANEOUS SKELETAL MUSCLE RELAXANTS;
Otc;
STERIMAX INC
DIN: 02047535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16522
SANDOZ ORPHENADRINE;
orphenadrine citrate 100 mg;
2001-02-27;
Oral;
Tablet (Extended-Release);
12:20.92 – MISCELLANEOUS SKELETAL MUSCLE RELAXANTS;
Otc;
SANDOZ CANADA INCORPORATED
DIN: 02243559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67477
TAMIFLU;
oseltamivir (oseltamivir phosphate) 30 mg;
2008-12-01;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02304848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79011
NAT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 30 mg;
2018-02-06;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02472635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96194
MAR-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02497352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98718
JAMP OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-09-24;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02497409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98723
MINT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-06-12;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02497441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98727
OSELTAMIVIR PHOSPHATE CAPSULES;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02504006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99346
TAMIFLU;
oseltamivir (oseltamivir phosphate) 45 mg;
2008-12-08;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02304856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79012
NAT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 45 mg;
2018-02-06;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02472643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96195
MAR-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 45 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02497360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98719
OSELTAMIVIR PHOSPHATE CAPSULES;
oseltamivir (oseltamivir phosphate) 45 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02504014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99347
TAMIFLU;
oseltamivir (oseltamivir phosphate) 6 mg / ml;
2012-09-10;
Oral;
Powder For Suspension;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02381842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86768
NAT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 6 mg / ml;
2020-09-29;
Oral;
Powder For Suspension;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02499894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98960
TAMIFLU CAPSULE 75MG;
oseltamivir (oseltamivir phosphate) 75 mg;
1999-12-23;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02241472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65111
NAT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 75 mg;
2016-09-29;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02457989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94501
MAR-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02497379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98720
JAMP OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-09-24;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02497425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98725
MINT-OSELTAMIVIR;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-05-29;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02497476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98729
OSELTAMIVIR PHOSPHATE CAPSULES;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02504022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99348
TAGRISSO;
osimertinib (osimertinib mesylate) 40 mg;
2016-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02456214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94310
TAGRISSO;
osimertinib (osimertinib mesylate) 80 mg;
2016-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02456222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94311
OXALIPLATIN INJECTION;
oxaliplatin 5 mg / ml;
2015-12-16;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02435071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91937
OXALIPLATIN INJECTION;
oxaliplatin 5 mg / ml;
2015-12-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02436957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92127
OXALIPLATIN;
oxaliplatin 5 mg / ml;
2015-12-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02444763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92996
TARO-OXALIPLATIN;
oxaliplatin 5 mg / ml;
2017-02-15;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02449692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93552
APO OXAZEPAM TAB 10MG;
oxazepam 10 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00402680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3463
OXAZEPAM 10 TAB 10MG;
oxazepam 10 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00497754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3806
RIVA OXAZEPAM;
oxazepam 10 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
DIN: 00568392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5563
APO OXAZEPAM TAB 15MG;
oxazepam 15 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00402745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3465
OXAZEPAM 15 TAB 15MG;
oxazepam 15 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00497762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3807
RIVA OXAZEPAM;
oxazepam 15 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
DIN: 00568406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5213
APO OXAZEPAM TAB 30MG;
oxazepam 30 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00402737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3464
OXAZEPAM 30 TAB 30MG;
oxazepam 30 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00497770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3808
RIVA OXAZEPAM;
oxazepam 30 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
DIN: 00568414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5214
APO-OXCARBAZEPINE;
oxcarbazepine 150 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02284294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76987
JAMP-OXCARBAZEPINE;
oxcarbazepine 150 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02440717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92508
TRILEPTAL 300 MG;
oxcarbazepine 300 mg;
2002-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65741
APO-OXCARBAZEPINE;
oxcarbazepine 300 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02284308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76988
JAMP-OXCARBAZEPINE;
oxcarbazepine 300 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02440725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92509
TRILEPTAL ORAL SUSPENSION;
oxcarbazepine 60 mg / ml;
2002-09-05;
Oral;
Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02244673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68661
TRILEPTAL 600 MG;
oxcarbazepine 600 mg;
2002-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65742
APO-OXCARBAZEPINE;
oxcarbazepine 600 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02284316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76989
JAMP-OXCARBAZEPINE;
oxcarbazepine 600 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02440733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92510
OXYTROL;
oxybutynin 3.9 mg / 24 hour;
2004-08-12;
Transdermal;
Patch;
86:12.04 – Antimuscarinics;
Prescription;
ALLERGAN INC
DIN: 02254735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73990
DITROPAN XL;
oxybutynin chloride 10 mg;
2001-06-22;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
JANSSEN INC
DIN: 02243961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67904
PMS-OXYBUTYNIN;
oxybutynin chloride 2.5 mg;
1999-11-22;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
DIN: 02240549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64119
APO-OXYBUTYNIN – TAB 5MG;
oxybutynin chloride 5 mg;
1995-12-31;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
APOTEX INC
DIN: 02163543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18355
TEVA-OXYBUTYNIN;
oxybutynin chloride 5 mg;
1997-02-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02230394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49219
PMS-OXYBUTYNIN;
oxybutynin chloride 5 mg;
1999-11-22;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
DIN: 02240550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64120
DITROPAN XL;
oxybutynin chloride 5 mg;
2001-06-22;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
JANSSEN INC
DIN: 02243960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67903
RIVA-OXYBUTYNIN;
oxybutynin chloride 5 mg;
2008-06-09;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02299364
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78474
OXYBUTYNIN;
oxybutynin chloride 5 mg;
2010-05-12;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
DIN: 02350238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83545
PMS-OXYBUTYNIN;
oxybutynin chloride 5 mg / 5 ml;
1996-09-04;
Oral;
Syrup;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
DIN: 02223376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43358
SUPEUDOL 10;
oxycodone hydrochloride 10 mg;
1973-12-31;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00392480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3551
SUPEUDOL 10;
oxycodone hydrochloride 10 mg;
1980-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00443948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3996
OXY.IR;
oxycodone hydrochloride 10 mg;
2000-03-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02240131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63645
PMS-OXYCODONE CR;
oxycodone hydrochloride 10 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02309882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79557
PMS-OXYCODONE;
oxycodone hydrochloride 10 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02319985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80543
APO-OXYCODONE CR;
oxycodone hydrochloride 10 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02366754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85158
OXYNEO;
oxycodone hydrochloride 10 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85760
OXYNEO;
oxycodone hydrochloride 15 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85765
APO-OXYCODONE CR;
oxycodone hydrochloride 15 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02394766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87990
SUPEUDOL 20;
oxycodone hydrochloride 20 mg;
1973-12-31;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00392472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3550
OXY.IR;
oxycodone hydrochloride 20 mg;
2000-03-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02240132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63646
SUPEUDOL;
oxycodone hydrochloride 20 mg;
2005-04-26;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02262983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74839
PMS-OXYCODONE CR;
oxycodone hydrochloride 20 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02309890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79558
PMS-OXYCODONE;
oxycodone hydrochloride 20 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02319993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80544
APO-OXYCODONE CR;
oxycodone hydrochloride 20 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02366762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85159
OXYNEO;
oxycodone hydrochloride 20 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85788
OXYNEO;
oxycodone hydrochloride 30 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85766
APO-OXYCODONE CR;
oxycodone hydrochloride 30 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02394774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87991
APO-OXYCODONE CR;
oxycodone hydrochloride 40 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02306530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79224
PMS-OXYCODONE CR;
oxycodone hydrochloride 40 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02309904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79559
OXYNEO;
oxycodone hydrochloride 40 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85767
SUPEUDOL 5;
oxycodone hydrochloride 5 mg;
1990-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00789739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10433
OXY.IR;
oxycodone hydrochloride 5 mg;
2000-03-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02231934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51386
PMS-OXYCODONE;
oxycodone hydrochloride 5 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02319977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80542
APO-OXYCODONE CR;
oxycodone hydrochloride 5 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02366746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85157
OXYNEO;
oxycodone hydrochloride 60 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85768
APO-OXYCODONE CR;
oxycodone hydrochloride 60 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02394782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87993
PMS-OXYCODONE CR;
oxycodone hydrochloride 80 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02309912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79560
APO-OXYCODONE CR;
oxycodone hydrochloride 80 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02366789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85161
OXYNEO;
oxycodone hydrochloride 80 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02372584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85769
OXYGEN 100%;
oxygen 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5682
OXYGENE – GAS INH;
oxygen 100 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PREVIMED INC.
DIN: 02170175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18663
OXYGEN USP – GAS 100%;
oxygen 100 %;
1996-07-30;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
LAKERIDGE HEALTH CORPORATION COMMUNITY RESPIRATORY SERVICES
DIN: 02219719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20349
OXYGEN 99.0%;
oxygen 99 %;
1986-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR PRODUCTS CANADA LTD/LTÉE.
DIN: 00591629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6826
OXYGEN 99%;
oxygen 99 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13886
OXYGEN USP;
oxygen 99 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02154838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19299
OXYGEN (COMPRESSED);
oxygen 99 %;
1999-03-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ST. THOMAS ELGIN GENERAL HOSPITAL
DIN: 02238428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61847
OXYGEN;
oxygen 99 %;
1999-07-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
DIN: 02238755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62190
OXYGEN USP;
oxygen 99 %;
2005-08-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
HURONIA/MED-E-OX LTD.
DIN: 02240621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64194
OXYGEN USP;
oxygen 99 %;
2000-07-13;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ONTARIO HOME OXYGEN AND RESPIRATORY SERVICE INC.
DIN: 02242542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66284
OXYGEN USP;
oxygen 99 %;
2000-12-19;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RIMER ALCO NORTH AMERICA INC.
DIN: 02243073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66939
OXYGEN USP;
oxygen 99 %;
2003-07-03;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
OXYMED, DIV. DE 118303 CANADA INC.
DIN: 02247852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72159
OXYGEN;
oxygen 99 %;
2003-11-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RESPIRATORY HOMECARE SOLUTIONS CANADA INC.
DIN: 02248123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72450
OXYGEN, COMPRESSED;
oxygen 99.2 %;
2000-11-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RESPIRATORY HOMECARE SOLUTIONS (VANCOUVER ISLAND), 0930469 B.C. LTD.
DIN: 02242508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66253
OXYGEN USP;
oxygen 99.5 %;
1993-10-21;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
GASPRO, DIVISION OF PRORESP INC.
DIN: 02052881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27306
OXYGEN;
oxygen 99.5 %;
2018-03-26;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ONTARIO MEDICAL OXYGEN SERVICES INC.
DIN: 02474298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96434
OXYGEN U.S.P.;
oxygen 99.99 %;
1997-03-11;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MAGGAS MEDICAL INC.
DIN: 02230956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50235
CLARITIN ALLERGY DECONGESTANT;
oxymetazoline hydrochloride 0.05 %;
2001-05-02;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02243690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67620
DRIXORAL NASAL CONGESTION;
oxymetazoline hydrochloride 0.05 %;
2012-08-15;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02380129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86596
EXTRA MOISTURIZING NASAL SPRAY;
oxymetazoline hydrochloride 0.05 %;
2015-07-08;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02428660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91311
NASAL CONGESTION SPRAY;
oxymetazoline hydrochloride 0.05 %;
2015-07-08;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02428679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91312
DRIXORAL DECONGESTANT NASAL SPRAY;
oxymetazoline hydrochloride 0.05 % / w/v;
1986-12-31;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 00740861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41903
LONG LASTING DRISTAN NASAL MIST;
oxymetazoline hydrochloride 0.05 % / w/v;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 01929372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41954
LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY;
oxymetazoline hydrochloride 0.05 % / w/v;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 01929380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41970
DRIXORAL NO DRIP EXTRA MOISTURIZING;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02245575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69670
DRIXORAL NO DRIP ORIGINAL UNSCENTED;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02245578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69673
DRIXORAL NO DRIP COOLING MENTHOL;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02245580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69676
SINUFRIN;
oxymetazoline hydrochloride 0.05 % / w/v;
2015-05-10;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
NEILMED PHARMACEUTICALS INC
DIN: 02439484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92387
SINUFRIN PLUS;
oxymetazoline hydrochloride 0.05 % / w/v;
2015-05-10;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
NEILMED PHARMACEUTICALS INC
DIN: 02439492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92388
LONG LASTING DECONGESTANT NASAL SPRAY;
oxymetazoline hydrochloride 0.05 % / w/v;
2017-05-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
DIN: 02454351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94094
EXTRA MOISTURIZING NASAL SPRAY;
oxymetazoline hydrochloride 0.05 % / w/v;
2018-06-27;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
JUNO OTC INC
DIN: 02460572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94800
NASAL CONGESTION SPRAY;
oxymetazoline hydrochloride 0.05 % / w/v;
2018-06-28;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
JUNO OTC INC
DIN: 02460599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94802
DRIXORAL NO DRIP NASAL CONGESTION;
oxymetazoline hydrochloride 0.05 % / w/v;
2021-03-08;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02498294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98807
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL;
oxymetazoline hydrochloride 0.05 % / w/v;
2021-03-08;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
DIN: 02498308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98808
OXYTOCIN INJECTION USP;
oxytocin 10 unit / ml;
1981-12-31;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
DIN: 00497398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4293
OXYTOCIN INJECTION, USP;
oxytocin 10 unit / ml;
1996-08-14;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02139561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31361
ZEPOSIA;
ozanimod (ozanimod hydrochloride) 0.92 mg;
2020-11-12;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
DIN: 02505991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99535
OZANEX;
ozenoxacin 1 % / w/w;
2018-01-04;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Prescription;
FERRER INTERNACIONAL, S.A.
DIN: 02463504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95159
ABRAXANE FOR INJECTABLE SUSPENSION;
paclitaxel 100 mg / vial;
2006-08-31;
Intravenous;
Powder For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02281066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76673
PACLITAXEL FOR INJECTION;
paclitaxel 6 mg / ml;
2001-10-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOLYSE PHARMA CORPORATION
DIN: 02244372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68340
PACLITAXEL INJECTION USP;
paclitaxel 6 mg / ml;
2015-03-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02320150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80560
PACLITAXEL INJECTION USP;
paclitaxel 6 mg / ml;
2014-07-02;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02391465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87681
IBRANCE;
palbociclib 100 mg;
2016-04-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02453169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93970
IBRANCE;
palbociclib 100 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02493543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98355
IBRANCE;
palbociclib 125 mg;
2016-04-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02453177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93971
IBRANCE;
palbociclib 125 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02493551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98356
IBRANCE;
palbociclib 75 mg;
2016-04-20;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02453150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93969
IBRANCE;
palbociclib 75 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02493535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98354
INVEGA SUSTENNA;
paliperidone (paliperidone palmitate) 100 mg / 1 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02354233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83943
INVEGA SUSTENNA;
paliperidone (paliperidone palmitate) 150 mg / 1.5 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02354241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83944
INVEGA TRINZA;
paliperidone (paliperidone palmitate) 175 mg / 0.875 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02455943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94281
INVEGA TRINZA;
paliperidone (paliperidone palmitate) 263 mg / 1.315 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02455986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94284
INVEGA TRINZA;
paliperidone (paliperidone palmitate) 350 mg / 1.75 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02455994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94285
INVEGA SUSTENNA;
paliperidone (paliperidone palmitate) 50 mg / 0.5 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02354217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83941
INVEGA TRINZA;
paliperidone (paliperidone palmitate) 525 mg / 2.625 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02456001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94286
INVEGA SUSTENNA;
paliperidone (paliperidone palmitate) 75 mg / 0.75 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02354225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83942
INVEGA;
paliperidone 3 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02300273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78559
INVEGA;
paliperidone 6 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02300281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78560
INVEGA;
paliperidone 9 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02300303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78561
SYNAGIS;
palivizumab 100 mg / ml;
2016-11-03;
Intramuscular;
Solution;
08:18.24 – MONOCLONAL ANTIBODIES;
Prescription , Schedule D;
ABBVIE CORPORATION
DIN: 02438364
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92274
SYNAGIS;
palivizumab 50 mg / 0.5 ml;
2016-11-03;
Intramuscular;
Solution;
08:18.24 – MONOCLONAL ANTIBODIES;
Prescription , Schedule D;
ABBVIE CORPORATION
DIN: 02438372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92275
ALOXI;
palonosetron (palonosetron hydrochloride) 0.25 mg / 5 ml;
2012-07-19;
Intravenous;
Solution;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02381710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86757
ALOXI;
palonosetron (palonosetron hydrochloride) 0.5 mg;
2012-08-07;
Oral;
Capsule;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02381729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86758
DIUREX WATER CAPLETS;
pamabrom 50 mg;
2001-03-12;
Oral;
Tablet;
40:28.00 – DIURETICS;
Otc;
ALVA-AMCO PHARMACAL COMPANIES, INC.
DIN: 02242893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66725
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 3 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 02244550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68533
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 3 mg / ml;
2004-03-01;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02246597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70784
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 6 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 02244551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68534
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 6 mg / ml;
2004-03-02;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02246598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70785
PAMIDRONATE DISODIUM OMEGA 6 MG/ML;
pamidronate disodium 6 mg / ml;
2006-05-24;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02249677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73448
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 9 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 02244552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68535
PAMIDRONATE DISODIUM FOR INJECTION;
pamidronate disodium 9 mg / ml;
2004-03-01;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02246599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70786
PAMIDRONATE DISODIUM OMEGA 9 MG/ML;
pamidronate disodium 9 mg / ml;
2005-07-27;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02249685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73449
VECTIBIX;
panitumumab 100 mg / 5 ml;
2008-05-27;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02308487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79412
VECTIBIX;
panitumumab 400 mg / 20 ml;
2017-01-03;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02308509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79414
MYLAN-PANTOPRAZOLE T;
pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg;
2015-08-31;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02408570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89331
PANTOPRAZOLE T;
pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg;
2017-10-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02466147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95445
TECTA;
pantoprazole (pantoprazole magnesium) 40 mg;
2006-03-15;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02267233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75263
TEVA-PANTOPRAZOLE MAGNESIUM;
pantoprazole (pantoprazole magnesium) 40 mg;
2015-11-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02440628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92500
PANTOPRAZOLE MAGNESIUM;
pantoprazole (pantoprazole magnesium) 40 mg;
2015-11-25;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTIUS HEALTHCARE INC
DIN: 02441853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92624
TEVA-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2008-04-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77096
SANDOZ PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2008-06-03;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02301075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78642
JAMP-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2014-02-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02408414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89317
PANTOPRAZOLE-20;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2014-07-21;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02428172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91265
TEVA-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-04-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77097
SANDOZ PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-06-03;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02301083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78643
RIVA-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-10-27;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80197
JAMP-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-12-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02357054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84215
PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2011-09-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02370808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85592
JAMP PANTOPRAZOLE SODIUM;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2021-03-18;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02392623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87788
AURO-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2016-02-06;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02415208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89982
MAR-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-07-18;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02416565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90116
MINT-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-01-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02417448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90206
PRIVA-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2015-01-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02425378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91002
PANTOPRAZOLE-40;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-07-21;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02428180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91266
PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-10-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02431327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91574
PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2015-05-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02437945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92231
BIO-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2016-11-24;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02445867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93114
M-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2017-11-01;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02467372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95575
PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2019-03-08;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02469138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95779
NRA-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-10-06;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02471825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96103
AG-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-07-17;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02478781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96927
AG-PANTOPRAZOLE SODIUM;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-12-27;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97204
PANTOPRAZOLE FOR INJECTION;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg / vial;
2017-10-20;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02458969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94611
PANTOLOC;
pantoprazole (pantoprazole sodium) 20 mg;
2000-05-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02241804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65469
APO-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium) 20 mg;
2008-03-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02292912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77826
PANTOLOC;
pantoprazole (pantoprazole sodium) 40 mg;
1997-03-05;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02229453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47339
APO-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium) 40 mg;
2008-03-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02292920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77827
RAN-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium) 40 mg;
2008-02-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02305046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79041
PMS-PANTOPRAZOLE;
pantoprazole (pantoprazole sodium) 40 mg;
2008-06-04;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02307871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79355
PANTOPRAZOLE;
pantoprazole (pantoprazole sodium) 40 mg;
2009-01-29;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02318695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80417
PANTOPRAZOLE SODIUM FOR INJECTION;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2008-03-11;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02306727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79242
PANTOPRAZOLE FOR INJECTION;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2010-12-14;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02352214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83745
PANTOPRAZOLE SODIUM FOR INJECTION;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2017-11-20;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02441527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92591
PAPAVERINE HYDROCHLORIDE INJECTION USP;
papaverine hydrochloride 65 mg / 2 ml;
1951-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00009881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=160
HUMATIN CAP 250MG;
paromomycin (paromomycin sulfate) 250 mg;
1994-12-31;
Oral;
Capsule;
08:30.04 – AMEBICIDES;
Prescription;
ERFA CANADA 2012 INC
DIN: 02078759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16701
TEVA-PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 10 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72911
PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 10 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87377
TEVA-PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 20 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72912
PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 20 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87378
TEVA-PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 30 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72913
PAROXETINE;
paroxetine (paroxetine hydrochloride acetone solvate) 30 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87379
RIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72914
AURO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02383276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86903
MAR-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02411946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89654
MINT-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90600
PRIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02444313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92928
BIO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93013
M-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-03-07;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02467402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95578
AG-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96560
PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02477823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96844
NRA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02479753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97010
RIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72915
AURO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02383284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86904
MAR-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02411954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89652
MINT-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90601
PRIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02444321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92929
BIO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93014
M-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-03-07;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02467410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95579
AG-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96561
PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02477831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96845
NRA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02479761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97011
RIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72916
AURO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02383292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86905
MAR-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02411962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89655
MINT-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90602
PRIVA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02444348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92930
BIO-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93015
M-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-07-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02467429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95580
AG-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96562
PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02477858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96846
NRA-PAROXETINE;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02479788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97012
PAXIL TAB 10MG;
paroxetine (paroxetine hydrochloride) 10 mg;
1997-01-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02027887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43575
APO-PAROXETINE;
paroxetine (paroxetine hydrochloride) 10 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02240907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64498
PMS-PAROXETINE;
paroxetine (paroxetine hydrochloride) 10 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72042
PAROXETINE-10;
paroxetine (paroxetine hydrochloride) 10 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02248913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73287
PAROXETINE;
paroxetine (paroxetine hydrochloride) 10 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02282844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76846
JAMP-PAROXETINE;
paroxetine (paroxetine hydrochloride) 10 mg;
2011-10-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85383
PAXIL CR;
paroxetine (paroxetine hydrochloride) 12.5 mg;
2004-01-05;
Oral;
Tablet (Extended-Release);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02248503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72855
PAXIL TAB 20MG;
paroxetine (paroxetine hydrochloride) 20 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01940481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14007
APO-PAROXETINE;
paroxetine (paroxetine hydrochloride) 20 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02240908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64499
PMS-PAROXETINE;
paroxetine (paroxetine hydrochloride) 20 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72043
PAROXETINE-20;
paroxetine (paroxetine hydrochloride) 20 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02248914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73288
PAROXETINE;
paroxetine (paroxetine hydrochloride) 20 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02282852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76847
JAMP-PAROXETINE;
paroxetine (paroxetine hydrochloride) 20 mg;
2011-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85384
PAXIL CR;
paroxetine (paroxetine hydrochloride) 25 mg;
2004-01-05;
Oral;
Tablet (Extended-Release);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02248504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72856
PAXIL TAB 30MG;
paroxetine (paroxetine hydrochloride) 30 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01940473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14006
APO-PAROXETINE;
paroxetine (paroxetine hydrochloride) 30 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02240909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64500
PMS-PAROXETINE;
paroxetine (paroxetine hydrochloride) 30 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72044
PAROXETINE-30;
paroxetine (paroxetine hydrochloride) 30 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02248915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73289
PAROXETINE;
paroxetine (paroxetine hydrochloride) 30 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02282860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76848
JAMP-PAROXETINE;
paroxetine (paroxetine hydrochloride) 30 mg;
2011-10-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85385
SIGNIFOR;
pasireotide (pasireotide diaspartate) 0.3 mg / ml;
2013-11-26;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02413299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89797
SIGNIFOR;
pasireotide (pasireotide diaspartate) 0.6 mg / ml;
2013-11-26;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02413302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89798
SIGNIFOR;
pasireotide (pasireotide diaspartate) 0.9 mg / ml;
2013-11-28;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02413310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89799
SIGNIFOR LAR;
pasireotide (pasireotide pamoate) 10 mg / vial;
2019-05-30;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02480425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97095
SIGNIFOR LAR;
pasireotide (pasireotide pamoate) 20 mg / vial;
2016-01-28;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02437252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92155
SIGNIFOR LAR;
pasireotide (pasireotide pamoate) 30 mg / vial;
2019-05-30;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02480433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97096
SIGNIFOR LAR;
pasireotide (pasireotide pamoate) 40 mg / vial;
2015-08-04;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02437260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92157
SIGNIFOR LAR;
pasireotide (pasireotide pamoate) 60 mg / vial;
2015-08-04;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
DIN: 02437279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92156
PATENT BLUE SODIUM INJECTION;
patent blue sodium 50 mg / 2 ml;
1979-12-31;
Intravenous , Subcutaneous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
GUERBET
DIN: 00405396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3486
VELTASSA;
patiromer (patiromer sorbitex calcium) 16.8 g / sachet;
2019-11-27;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
DIN: 02481367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97185
VELTASSA;
patiromer (patiromer sorbitex calcium) 8.4 g / sachet;
2020-03-09;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
DIN: 02481359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97184
ONPATTRO;
patisiran (patisiran sodium) 2 mg / ml;
2019-07-25;
Intravenous;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ALNYLAM NETHERLANDS B.V.
DIN: 02489252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97933
VOTRIENT;
pazopanib (pazopanib hydrochloride) 200 mg;
2010-08-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02352303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83758
ONCASPAR;
pegaspargase 750 unit / ml;
2017-06-01;
Intramuscular , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SERVIER CANADA INC
DIN: 02461900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94965
NEULASTA;
pegfilgrastim 10 mg / ml;
2004-03-12;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02249790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73463
FULPHILA;
pegfilgrastim 10 mg / ml;
2020-02-07;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
DIN: 02484153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97449
LAPELGA;
pegfilgrastim 6 mg / 0.6 ml;
2019-02-27;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
APOTEX INC
DIN: 02474565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96479
ZIEXTENZO;
pegfilgrastim 6 mg / 0.6 ml;
2020-06-15;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
DIN: 02497395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98722
NYVEPRIA;
pegfilgrastim 6 mg / 0.6 ml;
2021-01-18;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02506238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99556
PEGASYS;
peginterferon alfa-2a 180 mcg / 0.5 ml;
2003-08-14;
Subcutaneous;
Solution;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02248077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72399
PLEGRIDY;
peginterferon beta-1a 125 mcg / 0.5 ml;
2015-09-29;
Subcutaneous;
Liquid;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
BIOGEN CANADA INC
DIN: 02444399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92943
SOMAVERT;
pegvisomant 10 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02272199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75772
SOMAVERT;
pegvisomant 15 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02272202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75774
SOMAVERT;
pegvisomant 20 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02272210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75775
SOMAVERT;
pegvisomant 25 mg / vial;
2016-03-10;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Schedule D;
PFIZER CANADA ULC
DIN: 02448831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93460
SOMAVERT;
pegvisomant 30 mg / vial;
2016-03-10;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Schedule D;
PFIZER CANADA ULC
DIN: 02448858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93461
KEYTRUDA;
pembrolizumab 25 mg / ml;
2017-07-13;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
MERCK CANADA INC
DIN: 02456869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94388
PEMETREXED DISODIUM FOR INJECTION;
pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial;
2017-05-24;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92306
PEMETREXED DISODIUM FOR INJECTION;
pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial;
2017-05-29;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92307
ALIMTA;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2009-01-09;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
DIN: 02306433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79204
TARO-PEMETREXED;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2018-10-18;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02429195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91363
PEMETREXED DISODIUM FOR INJECTION;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2017-03-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02459434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94667
TARO-PEMETREXED;
pemetrexed (pemetrexed disodium) 1000 mg / vial;
2021-05-07;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02480492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97105
ALIMTA;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2004-08-03;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
DIN: 02253437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73841
PEMETREXED DISODIUM FOR INJECTION;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2017-03-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02394227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87938
TARO-PEMETREXED;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2017-02-15;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02429209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91364
CUPRIMINE;
penicillamine 250 mg;
1964-12-31;
Oral;
Capsule;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00016055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=287
PENICILLIN G SODIUM FOR INJECTION, USP;
penicillin g (penicillin g sodium) 1000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02220261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37244
PENICILLIN G SODIUM FOR INJECTION, USP;
penicillin g (penicillin g sodium) 10000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02220296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37246
PENICILLIN G SODIUM FOR INJECTION, USP;
penicillin g (penicillin g sodium) 5000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02220288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37245
BICILLIN L-A;
penicillin g benzathine 1200000 unit / 2 ml;
2008-06-11;
Intramuscular;
Suspension;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
PFIZER CANADA ULC
DIN: 02291924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77729
PEN-VK;
penicillin v potassium 300 mg;
1985-12-31;
Oral;
Tablet;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
AA PHARMA INC
DIN: 00642215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6421
PENTAMIDINE ISETIONATE FOR INJECTION BP;
pentamidine isetionate 300 mg / vial;
1998-09-10;
Intramuscular , Intravenous;
Powder For Solution;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
PFIZER CANADA ULC
DIN: 02183080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44273
ELMIRON;
pentosan polysulfate sodium 100 mg;
1993-12-31;
Oral;
Capsule;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JANSSEN INC
DIN: 02029448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14161
PENTOXIFYLLINE SR;
pentoxifylline 400 mg;
1997-01-14;
Oral;
Tablet (Extended-Release);
20:24.00 – HEMORRHEOLOGIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02230090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48622
FYCOMPA;
perampanel 10 mg;
2013-06-03;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88932
FYCOMPA;
perampanel 12 mg;
2013-05-17;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88928
FYCOMPA;
perampanel 2 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88927
FYCOMPA;
perampanel 4 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88929
FYCOMPA;
perampanel 6 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88930
FYCOMPA;
perampanel 8 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02404540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88931
DEFINITY;
perflutren 150 mcl / ml;
2002-02-16;
Intravenous;
Suspension;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
LANTHEUS MI CANADA INC
DIN: 02243173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67049
NEULEPTIL;
periciazine 10 mg;
1969-12-31;
Oral;
Capsule;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
DIN: 01926772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12425
NEULEPTIL;
periciazine 10 mg / ml;
1976-12-31;
Oral;
Drops;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
DIN: 01926756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13159
NEULEPTIL;
periciazine 5 mg;
1969-12-31;
Oral;
Capsule;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
DIN: 01926780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12653
COVERSYL;
perindopril erbumine 2 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
DIN: 02123274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16880
APO-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-03-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02289261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77465
AURO-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02459817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94713
TEVA-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02464985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95319
SANDOZ PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95921
PMS-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02470675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95968
RIVA-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02472015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96126
MAR-PERINDOPRIL;
perindopril erbumine 2 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02474824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96501
MINT-PERINDOPRIL;
perindopril erbumine 2 mg;
2019-03-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02476762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96760
JAMP PERINDOPRIL;
perindopril erbumine 2 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02477009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96775
PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02479877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97044
PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02481634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97209
AG-PERINDOPRIL;
perindopril erbumine 2 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97216
M-PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02482924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97332
PRIVA-PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97367
PERINDOPRIL ERBUMINE;
perindopril erbumine 2 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97901
NRA-PERINDOPRIL;
perindopril erbumine 2 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02489015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97907
BIO-PERINDOPRIL;
perindopril erbumine 2 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02501309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99093
COVERSYL;
perindopril erbumine 4 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
DIN: 02123282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16879
APO-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-03-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02289288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77466
AURO-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02459825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94714
TEVA-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02464993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95320
SANDOZ PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95922
PMS-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02470683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95969
RIVA-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02472023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96127
MAR-PERINDOPRIL;
perindopril erbumine 4 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02474832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96502
MINT-PERINDOPRIL;
perindopril erbumine 4 mg;
2019-01-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02476770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96761
JAMP PERINDOPRIL;
perindopril erbumine 4 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02477017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96776
PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02479885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97045
PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02481642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97210
AG-PERINDOPRIL;
perindopril erbumine 4 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97217
M-PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02482932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97333
PRIVA-PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97368
PERINDOPRIL ERBUMINE;
perindopril erbumine 4 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97902
NRA-PERINDOPRIL;
perindopril erbumine 4 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02489023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97908
BIO-PERINDOPRIL;
perindopril erbumine 4 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02501317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99094
COVERSYL;
perindopril erbumine 8 mg;
2003-09-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
DIN: 02246624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70814
APO-PERINDOPRIL;
perindopril erbumine 8 mg;
2007-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02289296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77467
AURO-PERINDOPRIL;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02459833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94715
TEVA-PERINDOPRIL;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02465000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95321
SANDOZ PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95923
PMS-PERINDOPRIL;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02470691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95970
RIVA-PERINDOPRIL;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02472031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96128
MAR-PERINDOPRIL;
perindopril erbumine 8 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02474840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96503
MINT-PERINDOPRIL;
perindopril erbumine 8 mg;
2019-01-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02476789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96762
JAMP PERINDOPRIL;
perindopril erbumine 8 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02477025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96777
PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02479893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97046
PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02481650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97211
AG-PERINDOPRIL;
perindopril erbumine 8 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97218
M-PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02482940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97334
PRIVA-PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483254
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97369
PERINDOPRIL ERBUMINE;
perindopril erbumine 8 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97903
NRA-PERINDOPRIL;
perindopril erbumine 8 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02489031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97909
BIO-PERINDOPRIL;
perindopril erbumine 8 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02501325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99095
NIX CREME RINSE;
permethrin 1 %;
1988-12-31;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 00771368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8964
KWELLADA-P CRÈME RINSE;
permethrin 1 %;
1998-11-16;
Topical;
Liquid;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
DIN: 02231480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50804
NIX DERMAL CREAM;
permethrin 5 %;
1999-07-01;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02219905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37239
KWELLADA-P LOTION;
permethrin 5 %;
1997-10-16;
Topical;
Lotion;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
DIN: 02231348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50657
PERPHENAZINE;
perphenazine 16 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00335096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2365
PERPHENAZINE;
perphenazine 2 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00335134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2368
PERPHENAZINE;
perphenazine 4 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00335126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2367
PERPHENAZINE;
perphenazine 8 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00335118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2366
PEDIACEL;
pertactin 3 mcg / 0.5 ml , pertussis toxoid 20 mcg / 0.5 ml , diphtheria toxoid 15 lf / 0.5 ml , tetanus toxoid 5 lf / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml , haemophilus influenzae type b-prp 10 mcg / 0.5 ml , tetanus protein 30 mcg / 0.5 ml , filamentous haemagglutinin 20 mcg / 0.5 ml , fimbriae 5 mcg / 0.5 ml;
2007-10-04;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02243167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67042
PERJETA;
pertuzumab 420 mg / 14 ml;
2013-05-08;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02405016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88984
BÉBÉ HEALING OINTMENT;
petrolatum 46.5 %;
2018-06-25;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CERAVE CANADA
DIN: 02473712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96311
OINTMENT WITH MOISTURIZING VITAMIN E;
petrolatum 95.7 % / w/w;
2014-03-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
DIN: 02399954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88479
PROTECTIVE OINTMENT;
petrolatum 98.79 % / w/w;
2010-06-04;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SMITH & NEPHEW INC
DIN: 02325578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81094
PYRIDIUM 100MG;
phenazopyridine hydrochloride 100 mg;
1981-12-31;
Oral;
Tablet;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00476714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4388
NARDIL;
phenelzine (phenelzine sulfate) 15 mg;
1981-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00476552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4309
PHENOBARB;
phenobarbital 100 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00178829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=408
PHENOBARB;
phenobarbital 15 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00178799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=405
PHENOBARB;
phenobarbital 30 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00178802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=406
PHENOBARB ELIXIR;
phenobarbital 5 mg / ml;
1965-12-31;
Oral;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00645575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6095
PHENOBARB;
phenobarbital 60 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00178810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=407
PHENOBARBITAL SODIUM INJECTION, USP;
phenobarbital sodium 120 mg / ml;
2008-02-29;
Intramuscular , Intravenous;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02304090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78940
PHENOBARBITAL SODIUM INJECTION, USP;
phenobarbital sodium 30 mg / ml;
2008-02-29;
Intramuscular , Intravenous;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02304082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78939
ORAVERSE;
phentolamine mesylate 0.4 mg / 1.7 ml;
2014-09-17;
Submucosal;
Solution;
12:16.04.04 – Non-Selective Alfa-Adrenergic Blocking Agents;
Prescription;
SEPTODONT
DIN: 02421666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90632
PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD;
phentolamine mesylate 5 mg / ml;
2001-06-15;
Intramuscular , Intravenous;
Solution;
12:16.04.04 – Non-Selective Alfa-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02243737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67670
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP;
phenylephrine (phenylephrine hydrochloride) 10 mg / ml;
1992-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 01953583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12889
HEMORRHOIDAL RELIEF OINTMENT;
phenylephrine hydrochloride 0.25 %;
1998-08-06;
Topical;
Ointment;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
PERRIGO INTERNATIONAL
DIN: 02230466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49424
MINIMS PHENYLEPHRINE HYDROCHLORIDE;
phenylephrine hydrochloride 10 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02148455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18759
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP;
phenylephrine hydrochloride 10 mg / ml;
2019-03-26;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
MARCAN PHARMACEUTICALS INC
DIN: 02477254
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96812
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP;
phenylephrine hydrochloride 10 mg / ml;
2021-06-02;
Intramuscular , Intravenous , Subcutaneous;
Solution;
52:32.00 – VASOCONSTRICTORS;
Ethical;
STERIMAX INC
DIN: 02504545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99396
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%;
phenylephrine hydrochloride 10 mg / 1 ml;
2001-07-30;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02238400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61817
MYDFRIN;
phenylephrine hydrochloride 2.5 % / w/v;
1979-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Ethical;
ALCON CANADA INC
DIN: 00465763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3319
MINIMS PHENYLEPHRINE HYDROCHLORIDE;
phenylephrine hydrochloride 2.5 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Ethical;
BAUSCH HEALTH, CANADA INC.
DIN: 02148447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18860
PHENYLEPHRINE HYDROCHLORIDE INJECTION;
phenylephrine hydrochloride 50 mcg / ml;
2016-11-04;
Intravenous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
BIOSYENT PHARMA INC
DIN: 02454599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94130
DILANTIN-125 SUSPENSION;
phenytoin 125 mg / 5 ml;
1953-12-31;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
DIN: 00023450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=613
TARO-PHENYTOIN;
phenytoin 125 mg / 5 ml;
2005-05-03;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02250896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73583
DILANTIN-30 SUSPENSION;
phenytoin 30 mg / 5 ml;
1968-12-31;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
DIN: 00023442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=769
DILANTIN INFATABS;
phenytoin 50 mg;
1952-12-31;
Oral;
Tablet;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
DIN: 00023698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1086
DILANTIN;
phenytoin sodium 100 mg;
1951-12-31;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
DIN: 00022780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1037
PHENYTOIN SODIUM;
phenytoin sodium 100 mg;
2017-08-16;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
AA PHARMA INC
DIN: 02460912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94843
DILANTIN;
phenytoin sodium 30 mg;
1951-12-31;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
DIN: 00022772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1036
PHENYTOIN SODIUM INJECTION USP;
phenytoin sodium 50 mg / ml;
1988-12-31;
Intramuscular , Intravenous;
Liquid;
28:12.12 – HYDANTOINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00780626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9398
PHENYTOIN SODIUM INJECTION, USP;
phenytoin sodium 50 mg / ml;
2015-03-12;
Intramuscular , Intravenous;
Solution;
28:12.12 – HYDANTOINS;
Prescription;
STERIMAX INC
DIN: 02431378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91579
ISOPTO CARPINE;
pilocarpine hydrochloride 2 %;
1959-12-31;
Ophthalmic;
Liquid;
52:40.20 – MIOTICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00000868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2375
ISOPTO CARPINE;
pilocarpine hydrochloride 4 %;
1959-12-31;
Ophthalmic;
Liquid;
52:40.20 – MIOTICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00000884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2374
SALAGEN;
pilocarpine hydrochloride 5 mg;
1997-04-01;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AMDIPHARM LIMITED
DIN: 02216345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43182
M-PILOCARPINE;
pilocarpine hydrochloride 5 mg;
2020-05-12;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MANTRA PHARMA INC
DIN: 02496119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98599
JAMP PILOCARPINE;
pilocarpine hydrochloride 5 mg;
2021-04-30;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02509571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99887
MINIMS PILOCARPINE NITRATE;
pilocarpine nitrate 2 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:40.20 – MIOTICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02148463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18744
ELIDEL;
pimecrolimus 1 % / w/w;
2003-03-24;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02247238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71480
PIMOZIDE;
pimozide 2 mg;
2003-04-01;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
DIN: 02245432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69484
PIMOZIDE;
pimozide 4 mg;
2003-04-01;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
DIN: 02245433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69485
DICETEL;
pinaverium bromide 100 mg;
1999-07-05;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
BGP PHARMA ULC
DIN: 02230684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49943
PINAVERIUM;
pinaverium bromide 100 mg;
2018-09-13;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
AA PHARMA INC
DIN: 02469685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95849
DICETEL;
pinaverium bromide 50 mg;
1993-12-31;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
BGP PHARMA ULC
DIN: 01950592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15176
PINAVERIUM;
pinaverium bromide 50 mg;
2018-09-13;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
AA PHARMA INC
DIN: 02469677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95848
VISKEN;
pindolol 10 mg;
1978-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
XEDITON PHARMACEUTICALS INC
DIN: 00443174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3091
APO-PINDOL TAB 10MG;
pindolol 10 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00755885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9168
TEVA-PINDOLOL;
pindolol 10 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00869015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10950
APO-PINDOL TAB 15MG;
pindolol 15 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00755893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9169
TEVA-PINDOLOL;
pindolol 15 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00869023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10951
VISKEN;
pindolol 5 mg;
1978-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
XEDITON PHARMACEUTICALS INC
DIN: 00417270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3089
APO-PINDOL TAB 5MG;
pindolol 5 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00755877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9167
TEVA-PINDOLOL;
pindolol 5 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00869007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10949
SANDOZ PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02297906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78323
ACT PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02302861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78818
APO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
DIN: 02302942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78824
PRO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
DIN: 02312050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79757
ACH-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2012-10-12;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02391600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87693
JAMP PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2014-12-12;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02397307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88227
SANDOZ PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02297914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78324
ACT PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02302888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78819
APO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
DIN: 02302950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78825
PRO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
DIN: 02312069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79758
ACH-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2010-06-11;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02339587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82518
JAMP PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2011-06-09;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02365529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85042
SANDOZ PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02297922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78325
ACT PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02302896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78820
APO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
DIN: 02302977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78827
PRO-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
DIN: 02312077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79759
ACH-PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2010-06-11;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02339595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82519
JAMP PIOGLITAZONE;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2011-06-09;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02365537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85043
ESBRIET;
pirfenidone 267 mg;
2013-01-08;
Oral;
Capsule;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02393751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87895
ESBRIET;
pirfenidone 267 mg;
2017-07-26;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02464489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95262
SANDOZ PIRFENIDONE TABLETS;
pirfenidone 267 mg;
2021-05-04;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02488507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97860
JAMP PIRFENIDONE;
pirfenidone 267 mg;
2021-06-04;
Oral;
Capsule;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02509938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99919
ESBRIET;
pirfenidone 801 mg;
2017-07-26;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02464500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95264
SANDOZ PIRFENIDONE TABLETS;
pirfenidone 801 mg;
2021-05-04;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02488515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97861
APO PIROXICAM CAP 10MG;
piroxicam 10 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00642886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6714
TEVA-PIROXICAM;
piroxicam 10 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00695718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6813
APO PIROXICAM CAP 20MG;
piroxicam 20 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00642894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6715
TEVA-PIROXICAM;
piroxicam 20 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00695696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6812
SANDOMIGRAN DS;
pizotifen (pizotifen malate) 1 mg;
1980-12-31;
Oral;
Tablet;
28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
Prescription;
PALADIN LABS INC.
DIN: 00511552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4222
MOZOBIL;
plerixafor 20 mg / ml;
2012-03-26;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02377225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86284
CONDYLINE;
podophyllotoxin 0.5 %;
1992-12-31;
Topical;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 01945149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12196
POLIVY;
polatuzumab vedotin 140 mg / vial;
2020-11-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02499614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98934
ALLERGENIC EXTRACT POLLENS;
pollen 100000 unit / ml;
1963-12-31;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 00299987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1914
NON STANDARDIZED ALLERGENIC EXTRACTS – POLLENS;
pollen 40000 unit / ml;
2012-02-10;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02372444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85756
CENTER-AL;
pollen and non pollen 20000 unit / ml;
1985-12-31;
Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 00648922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6237
LAX-A-DAY;
polyethylene glycol 3350 100 %;
2008-12-10;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02317680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80321
CLEARLAX;
polyethylene glycol 3350 100 %;
2010-11-05;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02324989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81040
RELAXA;
polyethylene glycol 3350 100 %;
2010-07-02;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MEDEXUS PHARMACEUTICALS INC
DIN: 02346672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83209
PEG 3350;
polyethylene glycol 3350 100 %;
2012-03-28;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MEDISCA PHARMACEUTIQUE INC
DIN: 02358034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84310
LAX-A-DAY MEN;
polyethylene glycol 3350 100 %;
2016-08-26;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02455617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94243
COMFILAX;
polyethylene glycol 3350 100 %;
2017-08-20;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02460297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94758
RESTORALAX;
polyethylene glycol 3350 100 % / w/w;
2009-10-16;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BAYER INC
DIN: 02318164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80366
PEGALAX;
polyethylene glycol 3350 100 % / w/w;
2009-09-17;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 02328232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81376
EMOLAX;
polyethylene glycol 3350 100 % / w/w;
2015-10-04;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
DIN: 02374137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85934
PURELAX;
polyethylene glycol 3350 100 % / w/w;
2014-07-10;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02415054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89967
M-PEG 3350;
polyethylene glycol 3350 100 % / w/w;
2017-03-13;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MANTRA PHARMA INC
DIN: 02450070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93607
LAX-A-DAY PHARMA;
polyethylene glycol 3350 100 % / w/w;
2016-08-30;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
DIN: 02453193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93973
HYDRALAX;
polyethylene glycol 3350 17 g / dose;
2019-04-26;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JUNO OTC INC
DIN: 02473119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96245
TEARS PLUS 1.4%;
polyvinyl alcohol 1.4 %;
1982-12-31;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 00579408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5121
REFRESH;
polyvinyl alcohol 1.4 %;
1995-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02138670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18791
POMALYST;
pomalidomide 1 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02419580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90423
POMALYST;
pomalidomide 2 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02419599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90424
POMALYST;
pomalidomide 3 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02419602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90425
POMALYST;
pomalidomide 4 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02419610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90426
ICLUSIG;
ponatinib (ponatinib hydrochloride) 15 mg;
2015-08-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ARIAD PHARMACEUTICALS INC
DIN: 02437333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92168
ICLUSIG;
ponatinib (ponatinib hydrochloride) 45 mg;
2016-01-07;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ARIAD PHARMACEUTICALS INC
DIN: 02437341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92169
CUROSURF;
poractant alfa 80 mg / ml;
2016-12-19;
Intratracheal;
Suspension;
48:36.00 – PULMONARY SURFACTANTS;
Prescription;
CHIESI FARMACEUTICI S.P.A.
DIN: 02241551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65204
POSANOL;
posaconazole 100 mg;
2014-05-21;
Oral;
Tablet (Delayed-Release);
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
DIN: 02424622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90930
SANDOZ POSACONAZOLE;
posaconazole 100 mg;
2020-12-08;
Oral;
Tablet (Delayed-Release);
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02496259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98612
POSANOL;
posaconazole 200 mg / 5 ml;
2007-06-06;
Oral;
Suspension;
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
DIN: 02293404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77877
POSANOL;
posaconazole 300 mg / 16.7 ml;
2014-11-24;
Intravenous;
Solution;
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
DIN: 02432676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91710
POTASSIUM ACETATE INJECTION USP;
potassium acetate 39.2 % / w/v;
2016-07-18;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02362597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84760
POTASSIUM CHLORIDE INJECTION;
potassium chloride 14.9 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 02241677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65337
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP;
potassium chloride 149 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
DIN: 00037869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2527
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP;
potassium chloride 149 mg / ml;
2020-03-25;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 02485699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97592
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE;
potassium chloride 20 meq / 10 ml;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00402206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3394
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE;
potassium chloride 200 meq / 100 ml;
2019-08-03;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02480034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97058
K + 45;
potassium chloride 251.6 g / l;
1990-12-31;
Dialysis;
Liquid;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 01905740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13833
POTASSIUM CHLORIDE INJECTION;
potassium chloride 29.8 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 02241679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65339
POTASSIUM CHLORIDE INJECTION;
potassium chloride 7.46 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 02241676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65336
UROCIT-K;
potassium citrate 1080 mg;
2011-02-11;
Oral;
Tablet (Extended-Release);
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
MISSION PHARMACAL COMPANY
DIN: 02353997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83921
UROCIT-K;
potassium citrate 540 mg;
1995-01-01;
Oral;
Tablet (Extended-Release);
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
MISSION PHARMACAL COMPANY
DIN: 01914022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46885
PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML;
potassium phosphate monobasic 176 mg / ml;
1987-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00711306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8119
NUCEIVA;
prabotulinumtoxina 100 unit / vial;
2019-10-16;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
EVOLUS INCORPORATED
DIN: 02480158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97069
FOLOTYN;
pralatrexate 20 mg / ml;
2019-01-15;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SERVIER CANADA INC
DIN: 02481820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97230
MIRAPEX;
pramipexole dihydrochloride monohydrate 0.125 mg;
2008-07-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02297256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78262
MIRAPEX;
pramipexole dihydrochloride monohydrate 0.25 mg;
1998-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02237145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60463
APO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
DIN: 02292378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77772
ACT PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02297302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78267
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02309122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79472
SANDOZ PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02315262
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80080
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02325802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81116
AURO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.25 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02424061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90879
APO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
DIN: 02292386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77773
ACT PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02297310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78268
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02309130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79473
SANDOZ PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02315270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80081
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02325810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81117
AURO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 0.5 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02424088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90880
APO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
DIN: 02292394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77774
ACT PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02297329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78269
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02309149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79474
SANDOZ PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02315289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80082
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02325829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81118
AURO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02424096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90881
APO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
DIN: 02292408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77776
ACT PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02297337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78270
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02309157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79475
SANDOZ PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02315297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80083
PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02325837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81119
AURO-PRAMIPEXOLE;
pramipexole dihydrochloride monohydrate 1.5 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02424118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90882
ITCH RELIEF BALM;
pramoxine hydrochloride 0.5 % / w/w;
2020-07-20;
Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02486385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97659
ITCH RELIEF MOISTURIZING LOTION;
pramoxine hydrochloride 1 %;
2021-02-01;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CERAVE CANADA
DIN: 02486881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97705
ITCH RELIEF MOISTURIZING CREAM;
pramoxine hydrochloride 1 % / w/w;
2021-02-01;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CERAVE CANADA
DIN: 02484889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97516
JAMP PRASUGREL;
prasugrel (prasugrel hydrochloride) 10 mg;
2021-05-14;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02502429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99200
APO-PRAVASTATIN;
pravastatin sodium 10 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02243506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67424
PRAVASTATIN-10;
pravastatin sodium 10 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02243824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67763
TEVA-PRAVASTATIN;
pravastatin sodium 10 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71241
PMS-PRAVASTATIN;
pravastatin sodium 10 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71918
TARO-PRAVASTATIN;
pravastatin sodium 10 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02284421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77000
MINT-PRAVASTATIN;
pravastatin sodium 10 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02317451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80298
JAMP-PRAVASTATIN;
pravastatin sodium 10 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81669
PRAVASTATIN;
pravastatin sodium 10 mg;
2010-11-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02356546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84168
PRAVASTATIN;
pravastatin sodium 10 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02389703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87519
ACH-PRAVASTATIN;
pravastatin sodium 10 mg;
2019-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02440644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92501
PRIVA-PRAVASTATIN;
pravastatin sodium 10 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93059
BIO-PRAVASTATIN;
pravastatin sodium 10 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02446251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93068
AURO-PRAVASTATIN;
pravastatin sodium 10 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02458977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94613
SANDOZ PRAVASTATIN TABLETS;
pravastatin sodium 10 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02468700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95718
AG-PRAVASTATIN;
pravastatin sodium 10 mg;
2020-01-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02476142
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96641
M-PRAVASTATIN;
pravastatin sodium 10 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02476274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96728
APO-PRAVASTATIN;
pravastatin sodium 20 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02243507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67425
PRAVASTATIN-20;
pravastatin sodium 20 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02243825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67764
TEVA-PRAVASTATIN;
pravastatin sodium 20 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71242
PMS-PRAVASTATIN;
pravastatin sodium 20 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71919
TARO-PRAVASTATIN;
pravastatin sodium 20 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02284448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77001
MINT-PRAVASTATIN;
pravastatin sodium 20 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02317478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80299
JAMP-PRAVASTATIN;
pravastatin sodium 20 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81670
PRAVASTATIN;
pravastatin sodium 20 mg;
2010-11-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02356554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84169
PRAVASTATIN;
pravastatin sodium 20 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02389738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87521
ACH-PRAVASTATIN;
pravastatin sodium 20 mg;
2020-02-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02440652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92502
PRIVA-PRAVASTATIN;
pravastatin sodium 20 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93060
BIO-PRAVASTATIN;
pravastatin sodium 20 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02446278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93069
AURO-PRAVASTATIN;
pravastatin sodium 20 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02458985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94614
SANDOZ PRAVASTATIN TABLETS;
pravastatin sodium 20 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02468719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95719
AG-PRAVASTATIN;
pravastatin sodium 20 mg;
2019-12-04;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02476150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96642
M-PRAVASTATIN;
pravastatin sodium 20 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02476282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96729
APO-PRAVASTATIN;
pravastatin sodium 40 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02243508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67426
PRAVASTATIN-40;
pravastatin sodium 40 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02243826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67765
TEVA-PRAVASTATIN;
pravastatin sodium 40 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71243
PMS-PRAVASTATIN;
pravastatin sodium 40 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02247657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71920
TARO-PRAVASTATIN;
pravastatin sodium 40 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02284456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77002
MINT-PRAVASTATIN;
pravastatin sodium 40 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02317486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80300
JAMP-PRAVASTATIN;
pravastatin sodium 40 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81671
PRAVASTATIN;
pravastatin sodium 40 mg;
2010-12-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02356562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84170
PRAVASTATIN;
pravastatin sodium 40 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02389746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87522
ACH-PRAVASTATIN;
pravastatin sodium 40 mg;
2020-02-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02440660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92503
PRIVA-PRAVASTATIN;
pravastatin sodium 40 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93061
BIO-PRAVASTATIN;
pravastatin sodium 40 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02446286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93070
AURO-PRAVASTATIN;
pravastatin sodium 40 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02458993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94615
SANDOZ PRAVASTATIN TABLETS;
pravastatin sodium 40 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02468727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95720
AG-PRAVASTATIN;
pravastatin sodium 40 mg;
2019-12-04;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02476169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96643
M-PRAVASTATIN;
pravastatin sodium 40 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02476290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96730
BILTRICIDE;
praziquantel 600 mg;
1997-04-24;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Prescription;
BAYER INC
DIN: 02230897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50175
APO-PRAZO TAB 1MG;
prazosin (prazosin hydrochloride) 1 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00882801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10828
TEVA-PRAZOSIN;
prazosin (prazosin hydrochloride) 1 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 01934198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12451
APO-PRAZO TAB 2MG;
prazosin (prazosin hydrochloride) 2 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00882828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10829
TEVA-PRAZOSIN;
prazosin (prazosin hydrochloride) 2 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 01934201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12452
APO-PRAZO TAB 5MG;
prazosin (prazosin hydrochloride) 5 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00882836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10830
TEVA-PRAZOSIN;
prazosin (prazosin hydrochloride) 5 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 01934228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12453
DERMATOP OINTMENT;
prednicarbate 0.1 % / w/w;
2001-03-21;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02227517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43464
DERMATOP EMOLLIENT CREAM;
prednicarbate 0.1 % / w/w;
2001-03-21;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02230642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49818
PEDIAPRED;
prednisolone (prednisolone sodium phosphate) 5 mg / 5 ml;
1998-09-23;
Oral;
Solution;
68:04.00 – ADRENALS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02230619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49795
PMS-PREDNISOLONE;
prednisolone (prednisolone sodium phosphate) 5 mg / 5 ml;
2002-03-19;
Oral;
Solution;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
DIN: 02245532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69619
PRED MILD;
prednisolone acetate 0.12 %;
1974-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
DIN: 00299405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1936
PRED FORTE;
prednisolone acetate 1 %;
1974-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
DIN: 00301175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1937
TEVA-PREDNISOLONE;
prednisolone acetate 1 %;
1986-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
TEVA CANADA LIMITED
DIN: 00700401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7042
SANDOZ PREDNISOLONE;
prednisolone acetate 1 %;
1993-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 01916203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13946
MINIMS PREDNISOLONE SODIUM PHOSPHATE;
prednisolone sodium phosphate 0.5 %;
1995-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02148498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18750
WINPRED;
prednisone 1 mg;
1978-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
AA PHARMA INC
DIN: 00271373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3076
TEVA-PREDNISONE;
prednisone 5 mg;
1967-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
DIN: 00021695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=507
APO PREDNISONE TAB 5MG;
prednisone 5 mg;
1982-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
DIN: 00312770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4732
TEVA-PREDNISONE;
prednisone 50 mg;
1972-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
DIN: 00232378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1286
APO PREDNISONE TAB 50MG;
prednisone 50 mg;
1982-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
DIN: 00550957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4736
LYRICA;
pregabalin 150 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75383
PMS-PREGABALIN;
pregabalin 150 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02359634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84463
TEVA-PREGABALIN;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84626
RIVA-PREGABALIN;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02377063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86264
SANDOZ PREGABALIN;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87624
TARO-PREGABALIN;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87807
APO-PREGABALIN;
pregabalin 150 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87942
PREGABALIN;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02396521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88158
PREGABALIN;
pregabalin 150 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02403722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88851
PREGABALIN;
pregabalin 150 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02405563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89035
MINT-PREGABALIN;
pregabalin 150 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02424207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90892
AURO-PREGABALIN;
pregabalin 150 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02433907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91829
JAMP-PREGABALIN;
pregabalin 150 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02436000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92034
ACH-PREGABALIN;
pregabalin 150 mg;
2021-05-31;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93573
M-PREGABALIN;
pregabalin 150 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
DIN: 02467321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95571
PREGABALIN;
pregabalin 150 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
DIN: 02474387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96446
NRA-PREGABALIN;
pregabalin 150 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
DIN: 02479168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96712
AG-PREGABALIN;
pregabalin 150 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97128
NAT-PREGABALIN;
pregabalin 150 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98485
LYRICA;
pregabalin 225 mg;
2009-11-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75385
TEVA-PREGABALIN;
pregabalin 225 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84628
TARO-PREGABALIN;
pregabalin 225 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87808
APO-PREGABALIN;
pregabalin 225 mg;
2013-05-09;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87943
PMS-PREGABALIN;
pregabalin 225 mg;
2013-02-19;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02398079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88302
ACH-PREGABALIN;
pregabalin 225 mg;
2021-05-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93575
NAT-PREGABALIN;
pregabalin 225 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98486
LYRICA;
pregabalin 25 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75379
PMS-PREGABALIN;
pregabalin 25 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02359596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84460
TEVA-PREGABALIN;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84620
RIVA-PREGABALIN;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02377039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86261
SANDOZ PREGABALIN;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87621
TARO-PREGABALIN;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87804
APO-PREGABALIN;
pregabalin 25 mg;
2013-06-06;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87939
PREGABALIN;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02396483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88153
PREGABALIN;
pregabalin 25 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02403692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88848
PREGABALIN;
pregabalin 25 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02405539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89032
MINT-PREGABALIN;
pregabalin 25 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02423804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90851
AURO-PREGABALIN;
pregabalin 25 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02433869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91825
JAMP-PREGABALIN;
pregabalin 25 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92031
ACH-PREGABALIN;
pregabalin 25 mg;
2021-05-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93569
M-PREGABALIN;
pregabalin 25 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
DIN: 02467291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95568
PREGABALIN;
pregabalin 25 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
DIN: 02474352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96443
NRA-PREGABALIN;
pregabalin 25 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
DIN: 02479117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96708
AG-PREGABALIN;
pregabalin 25 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97125
NAT-PREGABALIN;
pregabalin 25 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98482
LYRICA;
pregabalin 300 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75386
PMS-PREGABALIN;
pregabalin 300 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02359642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84464
TEVA-PREGABALIN;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84629
RIVA-PREGABALIN;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02377071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86265
SANDOZ PREGABALIN;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87625
TARO-PREGABALIN;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87809
APO-PREGABALIN;
pregabalin 300 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87944
PREGABALIN;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02396548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88159
PREGABALIN;
pregabalin 300 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02403730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88852
PREGABALIN;
pregabalin 300 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02405598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89037
JAMP-PREGABALIN;
pregabalin 300 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02436019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92035
ACH-PREGABALIN;
pregabalin 300 mg;
2021-05-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93576
AG-PREGABALIN;
pregabalin 300 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97129
NAT-PREGABALIN;
pregabalin 300 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98487
LYRICA;
pregabalin 50 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75380
PMS-PREGABALIN;
pregabalin 50 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02359618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84461
TEVA-PREGABALIN;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84623
RIVA-PREGABALIN;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02377047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86262
SANDOZ PREGABALIN;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87622
TARO-PREGABALIN;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87805
APO-PREGABALIN;
pregabalin 50 mg;
2013-06-06;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87940
PREGABALIN;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02396505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88156
PREGABALIN;
pregabalin 50 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02403706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88849
PREGABALIN;
pregabalin 50 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02405547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89033
MINT-PREGABALIN;
pregabalin 50 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02423812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90852
AURO-PREGABALIN;
pregabalin 50 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02433877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91826
JAMP-PREGABALIN;
pregabalin 50 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92032
ACH-PREGABALIN;
pregabalin 50 mg;
2021-05-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93570
M-PREGABALIN;
pregabalin 50 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
DIN: 02467305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95569
PREGABALIN;
pregabalin 50 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
DIN: 02474360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96444
NRA-PREGABALIN;
pregabalin 50 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
DIN: 02479125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96709
AG-PREGABALIN;
pregabalin 50 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97126
NAT-PREGABALIN;
pregabalin 50 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98483
LYRICA;
pregabalin 75 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
DIN: 02268434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75381
PMS-PREGABALIN;
pregabalin 75 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02359626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84462
TEVA-PREGABALIN;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02361183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84624
RIVA-PREGABALIN;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02377055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86263
SANDOZ PREGABALIN;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87623
TARO-PREGABALIN;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02392836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87806
APO-PREGABALIN;
pregabalin 75 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02394251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87941
PREGABALIN;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02396513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88157
PREGABALIN;
pregabalin 75 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02403714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88850
PREGABALIN;
pregabalin 75 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02405555
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89034
MINT-PREGABALIN;
pregabalin 75 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02424185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90890
AURO-PREGABALIN;
pregabalin 75 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02433885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91827
JAMP-PREGABALIN;
pregabalin 75 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92033
ACH-PREGABALIN;
pregabalin 75 mg;
2021-05-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02449854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93571
M-PREGABALIN;
pregabalin 75 mg;
2017-12-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
DIN: 02467313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95570
PREGABALIN;
pregabalin 75 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
DIN: 02474379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96445
NRA-PREGABALIN;
pregabalin 75 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
DIN: 02479133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96710
AG-PREGABALIN;
pregabalin 75 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97127
NAT-PREGABALIN;
pregabalin 75 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02494876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98484
4% CITANEST PLAIN DENTAL;
prilocaine hydrochloride 40 mg / ml;
2015-12-23;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02435276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91954
PRIMAQUINE;
primaquine phosphate 26.3 mg;
1945-12-31;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02017776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18330
PRIMIDONE;
primidone 125 mg;
1977-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES;
Prescription;
AA PHARMA INC
DIN: 00399310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2751
PRIMIDONE;
primidone 250 mg;
1977-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES;
Prescription;
AA PHARMA INC
DIN: 00396761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2750
PROCAINAMIDE HYDROCHLORIDE INJ. USP;
procainamide hydrochloride 100 mg / ml;
1995-12-31;
Intramuscular , Intravenous;
Solution;
24:04.04.04 – CLASS IA ANTIARRYTHMICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02184486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19357
MATULANE;
procarbazine (procarbazine hydrochloride) 50 mg;
1970-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
LEADIANT BIOSCIENCES, INC
DIN: 00012750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=938
PROCHLORAZINE;
prochlorperazine (prochlorperazine maleate) 10 mg;
2000-02-09;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES , 56:22.08 – ANTIHISTAMINES;
Prescription;
AA PHARMA INC
DIN: 00886432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=45324
PROCHLORAZINE;
prochlorperazine (prochlorperazine maleate) 5 mg;
2000-02-09;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES , 56:22.08 – ANTIHISTAMINES;
Prescription;
AA PHARMA INC
DIN: 00886440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=45325
SANDOZ PROCHLORPERAZINE;
prochlorperazine 10 mg;
1989-12-31;
Rectal;
Suppository;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00789720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9919
PROMETRIUM;
progesterone 100 mg;
1995-12-31;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
ORGANON CANADA INC.
DIN: 02166704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18500
ENDOMETRIN;
progesterone 100 mg;
2009-11-30;
Vaginal;
Vaginal Tablet, Effervescent;
68:32.00 – PROGESTINS;
Prescription;
FERRING INC
DIN: 02334992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82061
TEVA-PROGESTERONE;
progesterone 100 mg;
2015-04-16;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02439913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92431
REDDY-PROGESTERONE;
progesterone 100 mg;
2018-08-09;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
DR REDDY’S LABORATORIES INC
DIN: 02463113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95102
PMS-PROGESTERONE;
progesterone 100 mg;
2018-08-08;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
PHARMASCIENCE INC
DIN: 02476576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96745
AURO-PROGESTERONE;
progesterone 100 mg;
2020-03-16;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
AURO PHARMA INC
DIN: 02493578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98357
PMS-PROGESTERONE;
progesterone 200 mg;
2019-02-07;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
PHARMASCIENCE INC
DIN: 02480247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97078
ACT PROGESTERONE INJECTION;
progesterone 50 mg / ml;
2016-04-13;
Intramuscular;
Solution;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02446820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93234
CRINONE;
progesterone 8 %;
2000-05-20;
Vaginal;
Gel;
68:32.00 – PROGESTINS;
Prescription;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02241013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64606
HISTANTIL TAB 50MG;
promethazine hydrochloride 50 mg;
1983-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Otc;
PHARMASCIENCE INC
DIN: 00575186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5369
RYTHMOL;
propafenone hydrochloride 150 mg;
1988-12-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
BGP PHARMA ULC
DIN: 00603708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8464
APO-PROPAFENONE;
propafenone hydrochloride 150 mg;
2001-02-22;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
DIN: 02243324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67227
PROPAFENONE;
propafenone hydrochloride 150 mg;
2010-02-16;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
SANIS HEALTH INC
DIN: 02343053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82854
MYLAN-PROPAFENONE;
propafenone hydrochloride 150 mg;
2017-10-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02457172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94425
RYTHMOL;
propafenone hydrochloride 300 mg;
1988-12-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
BGP PHARMA ULC
DIN: 00603716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8465
APO-PROPAFENONE;
propafenone hydrochloride 300 mg;
2001-02-22;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
DIN: 02243325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67228
PROPAFENONE;
propafenone hydrochloride 300 mg;
2010-02-16;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
SANIS HEALTH INC
DIN: 02343061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82855
MYLAN-PROPAFENONE;
propafenone hydrochloride 300 mg;
2017-10-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02457164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94424
ALCAINE;
proparacaine hydrochloride 0.5 % / w/v;
1971-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Ethical;
ALCON CANADA INC
DIN: 00035076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1172
MICTORYL;
propiverine hydrochloride 30 mg;
2017-05-08;
Oral;
Capsule (Controlled-Delivery);
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
DIN: 02460262
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94755
MICTORYL;
propiverine hydrochloride 45 mg;
2017-05-08;
Oral;
Capsule (Controlled-Delivery);
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
DIN: 02460270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94756
MICTORYL PEDIATRIC;
propiverine hydrochloride 5 mg;
2017-04-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
DIN: 02460289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94757
DIPRIVAN 1%;
propofol 10 mg / ml;
1993-12-31;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02018950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14476
PROPOFOL INJECTION;
propofol 10 mg / ml;
2002-03-01;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
BAXTER CORPORATION
DIN: 02244379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68347
PROPOFOL INJECTION;
propofol 10 mg / ml;
2015-06-01;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02437643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92203
TEVA-PROPOFOL;
propofol 10 mg / ml;
2015-11-20;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02437961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92233
PROPOFOL;
propofol 10 mg / ml;
2018-04-24;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
BAXTER CORPORATION
DIN: 02468336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95676
HEMANGIOL;
propranolol (propranolol hydrochloride) 3.75 mg / ml;
2017-03-23;
Oral;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PIERRE FABRE DERMO-COSMETIQUE CANADA INC
DIN: 02457857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94488
PROPRANOLOL HYDROCHLORIDE INJECTION USP;
propranolol hydrochloride 1 mg / ml;
1996-10-04;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02225883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43431
TEVA-PROPRANOLOL;
propranolol hydrochloride 10 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00496480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4254
INDERAL-LA;
propranolol hydrochloride 120 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02042266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16124
INDERAL-LA;
propranolol hydrochloride 160 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02042274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16579
TEVA-PROPRANOLOL;
propranolol hydrochloride 20 mg;
1987-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00740675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7349
TEVA-PROPRANOLOL;
propranolol hydrochloride 40 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00496499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4255
INDERAL-LA;
propranolol hydrochloride 60 mg;
1995-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02042231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17780
TEVA-PROPRANOLOL;
propranolol hydrochloride 80 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00496502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4256
INDERAL-LA;
propranolol hydrochloride 80 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02042258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16123
PROTAMINE SULFATE INJECTION, USP;
protamine sulfate 10 mg / ml;
1989-12-31;
Intravenous;
Solution;
20:28.08 – ANTIHEPARIN AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02139537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19443
PROTAMINE SULFATE INJECTION USP;
protamine sulfate 10 mg / ml;
1998-03-03;
Intravenous;
Solution;
20:28.08 – ANTIHEPARIN AGENTS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02231674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51049
RESOTRAN;
prucalopride (prucalopride succinate) 1 mg;
2012-01-12;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JANSSEN INC
DIN: 02377012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86259
APO-PRUCALOPRIDE;
prucalopride (prucalopride succinate) 1 mg;
2020-01-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
APOTEX INC
DIN: 02491591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98158
JAMP PRUCALOPRIDE;
prucalopride (prucalopride succinate) 1 mg;
2021-02-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02493489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98349
RESOTRAN;
prucalopride (prucalopride succinate) 2 mg;
2012-01-12;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JANSSEN INC
DIN: 02377020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86260
APO-PRUCALOPRIDE;
prucalopride (prucalopride succinate) 2 mg;
2020-01-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
APOTEX INC
DIN: 02491605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98159
JAMP PRUCALOPRIDE;
prucalopride (prucalopride succinate) 2 mg;
2021-02-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02493497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98350
TUBERSOL;
purified protein derivative of tuberculin 5 tub / 0.1 ml;
1975-12-31;
Intradermal;
Solution;
36:84.00 – TUBERCULOSIS;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 00317268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2087
COMBANTRIN TAB 125MG;
pyrantel (pyrantel pamoate) 125 mg;
1973-12-31;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 01944363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12926
JAMP-PYRANTEL PAMOATE;
pyrantel (pyrantel pamoate) 125 mg;
2013-12-13;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02380617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86640
JAMP-PYRANTEL PAMOATE SUSPENSION;
pyrantel (pyrantel pamoate) 50 mg / ml;
2014-03-25;
Oral;
Suspension;
08:08.00 – ANTHELMINTICS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02412470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89708
PDP-PYRAZINAMIDE;
pyrazinamide 500 mg;
1984-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00618810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6130
MESTINON-SR;
pyridostigmine bromide 180 mg;
1991-12-31;
Oral;
Tablet (Extended-Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00869953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11135
MESTINON;
pyridostigmine bromide 60 mg;
1990-12-31;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00869961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10567
RIVA-PYRIDOSTIGMINE;
pyridostigmine bromide 60 mg;
2020-08-24;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02495643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98554
PYRIDOXINE HYDROCHLORIDE INJECTION, USP;
pyridoxine hydrochloride 100 mg / ml;
2002-06-01;
Intramuscular , Intravenous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02245215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69230
ZINC ZAP SPRAY;
pyrithione zinc 0.2 %;
2000-10-19;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
NUTRIMMUNE TECHNOLOGIES INCORPORATED
DIN: 02242702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66499
SMOOTH AND SILKY LISSE ET SOYEUX DANDRUFF PYRITHIONE ZINC CONDITIONER;
pyrithione zinc 0.3 % / w/w;
2020-01-21;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02494299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98432
HEAD & SHOULDERS DANDRUFF CONDITIONER;
pyrithione zinc 0.5 %;
2008-02-22;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02244286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68253
HEAD & SHOULDERS NOURISHING HAIR & SCALP CARE CONDITIONER;
pyrithione zinc 0.5 %;
2016-01-04;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02440911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92528
HEAD & SHOULDERS INSTANT COOLING RELIEF CONDITIONER;
pyrithione zinc 0.5 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02429292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91372
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME STRENGTHEN;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98148
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME NOURISH;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98150
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME PURIFY & HYDRATE;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98151
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME COLOUR PROTECT;
pyrithione zinc 0.5 % / w/w;
2020-10-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02502720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99227
LIFE DANDRUFF SHAMPOO;
pyrithione zinc 1 %;
2003-12-06;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
DIN: 02245769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69880
LIFE -SHAMPOOING ET REVITALISANT ANTIPELLICULAIRE CLASSIQUE – 2 EN 1;
pyrithione zinc 1 %;
2003-09-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
DIN: 02246089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70224
T/GEL DAILY CONTROL 2 IN 1;
pyrithione zinc 1 %;
2004-08-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
JOHNSON & JOHNSON INC
DIN: 02251159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73611
SHAMPOOING 2 EN 1 ANTIPELLICULAIRE;
pyrithione zinc 1 %;
2004-12-20;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
DIN: 02255618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74079
PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN;
pyrithione zinc 1 %;
2004-12-20;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
DIN: 02258404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74361
LIFE BRAND ITCHY DRY SCALP ANTI-DANDRUFF SHAMPOO;
pyrithione zinc 1 %;
2013-02-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CRLS
DIN: 02382008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86787
SMOOTH AND SILKY LISSE ET SOYEUX DANDRUFF PYRITHIONE ZINC SHAMPOO;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02479036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96974
ORIGINAL / ORIGINALE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02479044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96975
GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02479052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96976
CLEANSING NETTOYANT DANDRUFF PYRITHIONE ZINC SHAMPOO;
pyrithione zinc 1 %;
2019-11-09;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02479079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96978
GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER;
pyrithione zinc 1 %;
2019-11-09;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
DIN: 02479095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96980
PERT ANTI-DANDRUFF;
pyrithione zinc 1 % / w/w;
2007-08-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
IDELLE LABS LTD
DIN: 02297892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78321
SELSUN BLUE ANTI-DANDRUFF SHAMPOO;
pyrithione zinc 1 % / w/w;
2009-11-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02320320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80576
DOVE MEN+CARE FORTIFYING SHAMPOO + CONDITIONER ANTI-DANDRUFF 2 IN 1;
pyrithione zinc 1 % / w/w;
2011-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02357739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84283
HEAD & SHOULDERS ITCHY SCALP CARE;
pyrithione zinc 1 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88440
HEAD & SHOULDERS DRY SCALP CARE 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88442
HEAD & SHOULDERS GREEN APPLE;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399555
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88443
HEAD & SHOULDERS GREEN APPLE 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88444
HEAD & SHOULDERS OCEAN LIFT 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88447
HEAD & SHOULDERS OCEAN LIFT;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88448
HEAD & SHOULDERS CLASSIC CLEAN 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88449
HEAD & SHOULDERS CLASSIC CLEAN;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88450
HEAD & SHOULDERS CITRUS BREEZE;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88452
HEAD & SHOULDERS DRY SCALP CARE;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88453
HEAD & SHOULDERS ITCHY SCALP CARE 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88454
HEAD & SHOULDERS SMOOTH & SILKY;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88455
HEAD & SHOULDERS SMOOTH & SILKY 2IN1;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02399709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88456
HEAD & SHOULDERS PURELY GENTLE SCALP CARE;
pyrithione zinc 1 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02400634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88540
HEAD & SHOULDERS PURELY GENTLE SCALP CARE 2IN1;
pyrithione zinc 1 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02400642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88542
HEAD & SHOULDERS INSTANT COOLING RELIEF;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02422077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90679
HEAD & SHOULDERS INSTANT COOLING RELIEF 2IN1;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02422123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90684
SCALPSYNC ANTI-DANDRUFF;
pyrithione zinc 1 % / w/w;
2014-07-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
MATRIX CANADA
DIN: 02425580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91022
HEAD & SHOULDERS INSTANT OIL CONTROL;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02426080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91069
HEAD & SHOULDERS INSTANT OIL CONTROL 2IN1;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02426099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91070
MEN EXPERT ANTI-DANDRUFF 2 IN 1;
pyrithione zinc 1 % / w/w;
2015-02-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
L’ OREAL CANADA
DIN: 02430436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91489
NOURISHING CARE;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02432846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91726
NOURISHING CARE 2IN1;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02432862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91727
PYRITHIONE ZINC DANDRUFF SHAMPOO AND CONDITIONER CLASSIC CLEAN 2 IN 1;
pyrithione zinc 1 % / w/w;
2016-04-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02448769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93449
PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN;
pyrithione zinc 1 % / w/w;
2016-04-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02448912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93469
PYRITHIONE ZINC DANDRUFF SHAMPOO REFRESH;
pyrithione zinc 1 % / w/w;
2016-05-17;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02449986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93592
PYRITHIONE ZINC DANDRUFF SHAMPOO SCALP CARE;
pyrithione zinc 1 % / w/w;
2016-06-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02449994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93593
PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS;
pyrithione zinc 1 % / w/w;
2016-04-27;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02450011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93597
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DANDRUFF DEFENSE 2 IN 1;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02465515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95369
DOVE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02466090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95440
DOVE DERMA+CARE SCALP ANTI-DANDRUFF FRESH & CLEAN 2 IN 1;
pyrithione zinc 1 % / w/w;
2018-02-18;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02466104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95441
DOVE DERMA+CARE SCALP ANTI-DANDRUFF FRESH & CLEAN;
pyrithione zinc 1 % / w/w;
2018-03-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02466112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95442
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF 2 IN 1;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02467194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95558
DOVE DERMA+CARE SCALP ANTI-DANDRUFF SMOOTHING MOISTURE;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02467208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95559
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF GENTLE CLEAN 2 IN 1;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02467216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95560
2IN1 MEN ADVANCED SERIES CHARCOAL;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96691
MEN ADVANCED SERIES CHARCOAL;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96697
MEN ADVANCED SERIES FULL & THICK;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96698
2IN1 MEN ADVANCED SERIES FULL & THICK;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96699
2IN1 MEN ADVANCED SERIES REFRESHING MENTHOL;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96700
MEN ADVANCED SERIES REFRESHING MENTHOL;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96701
2IN1 MEN ADVANCED SERIES SWAGGER;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96721
MEN ADVANCED SERIES SWAGGER;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02476266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96727
2IN1 MEN ADVANCED SERIES PURE SPORT;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02477211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96806
MEN ADVANCED SERIES PURE SPORT;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02477238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96807
2IN1 MEN ADVANCED SERIES FIJI;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02477289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96824
DOVE MEN PLUS CARE DERMA PLUS CARE SCALP ANTI-DANDRUFF DEEP CLEAN 2 IN 1;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02480174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97071
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF ALOE & RESTORE;
pyrithione zinc 1 % / w/w;
2019-12-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02480182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97072
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF INVIGORATING MINT;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02480190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97073
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF INVIGORATING MINT 2 IN 1;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
DIN: 02480204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97074
SCALP RELIEF;
pyrithione zinc 1 % / w/w;
2020-05-26;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
REDKEN 5TH AVENUE NYC
DIN: 02488132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97824
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME NOURISH;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98145
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME STRENGTHEN;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98146
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME PURIFY & HYDRATE;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02491478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98147
2IN1 MEN ADVANCED SERIES BOURBON;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02492873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98287
2IN1 MEN ADVANCED SERIES SAGE & MINT;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02492881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98288
2IN1 MEN ADVANCED SERIES SANDALWOOD;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02492903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98289
ALOE VERA 2IN1;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02493721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98372
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME COLOUR PROTECT;
pyrithione zinc 1 % / w/w;
2020-11-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02502763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99231
SHAMPOO CONTROL – 2%;
pyrithione zinc 2 %;
1996-06-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
AG HAIR LTD
DIN: 02207389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37795
SEROQUEL;
quetiapine (quetiapine fumarate) 100 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02236952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60246
TEVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76979
PMS-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02296578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78189
APO-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02313928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79944
SANDOZ QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02314002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79952
ACT QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80162
RIVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80221
PRO-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02317354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80288
QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02317907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80342
JAMP-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81616
QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02353172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83839
QUETIAPINE TABLETS;
quetiapine (quetiapine fumarate) 100 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02387808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87338
AURO-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02390213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87567
RAN-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02397102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88210
MINT-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02438011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92238
NAT-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92354
BIO-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2016-09-07;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
DIN: 02447207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93277
AG-QUETIAPINE;
quetiapine (quetiapine fumarate) 100 mg;
2018-09-25;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96638
TEVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 150 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76980
SEROQUEL XR;
quetiapine (quetiapine fumarate) 150 mg;
2009-04-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02321513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80692
QUETIAPINE TABLETS;
quetiapine (quetiapine fumarate) 150 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02387816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87339
TEVA-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 150 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88054
SANDOZ QUETIAPINE XRT;
quetiapine (quetiapine fumarate) 150 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02407698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89244
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 150 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02417367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90199
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 150 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02417790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90241
NAT-QUETIAPINE;
quetiapine (quetiapine fumarate) 150 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92355
ACH-QUETIAPINE FUMARATE XR;
quetiapine (quetiapine fumarate) 150 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02450879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93700
APO-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 150 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02457237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94431
SEROQUEL;
quetiapine (quetiapine fumarate) 200 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02236953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60247
TEVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76981
PMS-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02296594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78191
SEROQUEL XR;
quetiapine (quetiapine fumarate) 200 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02300192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78551
APO-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02313936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79945
SANDOZ QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02314010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79953
ACT QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80164
RIVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80223
PRO-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02317362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80289
QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02317923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80344
JAMP-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81618
QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02353199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83841
QUETIAPINE TABLETS;
quetiapine (quetiapine fumarate) 200 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02387824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87340
AURO-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02390248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87569
TEVA-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 200 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88055
RAN-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02397110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88211
SANDOZ QUETIAPINE XRT;
quetiapine (quetiapine fumarate) 200 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02407701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89241
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 200 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02417375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90200
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 200 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02417804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90242
MINT-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02438046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92240
NAT-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92356
BIO-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
DIN: 02447223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93279
ACH-QUETIAPINE FUMARATE XR;
quetiapine (quetiapine fumarate) 200 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02450887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93701
APO-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 200 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02457245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94432
AG-QUETIAPINE;
quetiapine (quetiapine fumarate) 200 mg;
2018-09-26;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96639
SEROQUEL;
quetiapine (quetiapine fumarate) 25 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02236951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60245
TEVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76978
PMS-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02296551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78188
APO-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02313901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79943
SANDOZ QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79951
ACT QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80161
RIVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80220
PRO-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02317346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80287
QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02317893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80341
JAMP-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81615
QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02353164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83838
QUETIAPINE TABLETS;
quetiapine (quetiapine fumarate) 25 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02387794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87337
AURO-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02390205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87566
RAN-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02397099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88209
MINT-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02438003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92237
NAT-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92353
PRIVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMAPAR INC
DIN: 02447088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93265
BIO-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
DIN: 02447193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93276
AG-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2018-09-25;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96637
NRA-QUETIAPINE;
quetiapine (quetiapine fumarate) 25 mg;
2019-09-23;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NORA PHARMA INC
DIN: 02486237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97646
SEROQUEL;
quetiapine (quetiapine fumarate) 300 mg;
2001-08-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02244107
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68066
TEVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76982
PMS-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02296608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78192
SEROQUEL XR;
quetiapine (quetiapine fumarate) 300 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02300206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78552
APO-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02313944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79946
SANDOZ QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02314029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79954
ACT QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80165
RIVA-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80224
PRO-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02317370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80290
QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02317931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80345
JAMP-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2010-06-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02330466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81619
QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02353202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83842
QUETIAPINE TABLETS;
quetiapine (quetiapine fumarate) 300 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02387832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87341
AURO-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02390256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87570
TEVA-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 300 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88056
RAN-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02397129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88212
SANDOZ QUETIAPINE XRT;
quetiapine (quetiapine fumarate) 300 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02407728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89242
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 300 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02417383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90201
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 300 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02417812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90243
MINT-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02438054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92241
NAT-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02439190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92357
BIO-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
DIN: 02447258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93280
ACH-QUETIAPINE FUMARATE XR;
quetiapine (quetiapine fumarate) 300 mg;
2021-01-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02450895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93702
APO-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 300 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02457253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94433
AG-QUETIAPINE;
quetiapine (quetiapine fumarate) 300 mg;
2018-09-26;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02476002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96640
SEROQUEL XR;
quetiapine (quetiapine fumarate) 400 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02300214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78553
TEVA-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 400 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88057
SANDOZ QUETIAPINE XRT;
quetiapine (quetiapine fumarate) 400 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02407736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89243
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 400 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02417391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90202
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 400 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02417820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90244
ACH-QUETIAPINE FUMARATE XR;
quetiapine (quetiapine fumarate) 400 mg;
2020-10-29;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02450909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93703
APO-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 400 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02457261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94434
SEROQUEL XR;
quetiapine (quetiapine fumarate) 50 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02300184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78550
PMS-QUETIAPINE;
quetiapine (quetiapine fumarate) 50 mg;
2011-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02361892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84693
TEVA-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 50 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88053
SANDOZ QUETIAPINE XRT;
quetiapine (quetiapine fumarate) 50 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02407671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89240
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 50 mg;
2014-01-01;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02417359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90198
QUETIAPINE XR;
quetiapine (quetiapine fumarate) 50 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02417782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90240
ACH-QUETIAPINE FUMARATE XR;
quetiapine (quetiapine fumarate) 50 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02450860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93699
APO-QUETIAPINE XR;
quetiapine (quetiapine fumarate) 50 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02457229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94430
NORPROLAC;
quinagolide (quinagolide hydrochloride) 0.025 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
DIN: 02223740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43389
NORPROLAC;
quinagolide (quinagolide hydrochloride) 0.05 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
DIN: 02223759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43390
NORPROLAC;
quinagolide (quinagolide hydrochloride) 0.075 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
DIN: 02223767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43391
NORPROLAC;
quinagolide (quinagolide hydrochloride) 0.15 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
DIN: 02223775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43392
ACCUPRIL TAB 10MG;
quinapril (quinapril hydrochloride) 10 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 01947672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12332
APO-QUINAPRIL;
quinapril (quinapril hydrochloride) 10 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72852
PMS-QUINAPRIL;
quinapril (quinapril hydrochloride) 10 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02340569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82614
ACCUPRIL TAB 20MG;
quinapril (quinapril hydrochloride) 20 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 01947680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12333
APO-QUINAPRIL;
quinapril (quinapril hydrochloride) 20 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72853
PMS-QUINAPRIL;
quinapril (quinapril hydrochloride) 20 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02340577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82615
ACCUPRIL TAB 40MG;
quinapril (quinapril hydrochloride) 40 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 01947699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12334
APO-QUINAPRIL;
quinapril (quinapril hydrochloride) 40 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72854
PMS-QUINAPRIL;
quinapril (quinapril hydrochloride) 40 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02340585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82616
ACCUPRIL 5MG TAB;
quinapril (quinapril hydrochloride) 5 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 01947664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12331
APO-QUINAPRIL;
quinapril (quinapril hydrochloride) 5 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72851
PMS-QUINAPRIL;
quinapril (quinapril hydrochloride) 5 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02340550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82613
TEVA-QUININE;
quinine sulfate 200 mg;
1966-12-31;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
TEVA CANADA LIMITED
DIN: 00021008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=651
QUININE – ODAN;
quinine sulfate 200 mg;
1999-05-01;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
ODAN LABORATORIES LTD
DIN: 00695440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=38055
APO-QUININE;
quinine sulfate 200 mg;
2004-06-08;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
APOTEX INC
DIN: 02254514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73941
PRO-QUININE – 200;
quinine sulfate 200 mg;
2008-07-03;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
PRO DOC LIMITEE
DIN: 02311216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79680
JAMP-QUININE;
quinine sulfate 200 mg;
2015-09-16;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02445190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93042
TEVA-QUININE;
quinine sulfate 300 mg;
1966-12-31;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
TEVA CANADA LIMITED
DIN: 00021016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=290
QUININE – ODAN;
quinine sulfate 300 mg;
1999-05-01;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
ODAN LABORATORIES LTD
DIN: 00695459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=38056
APO-QUININE;
quinine sulfate 300 mg;
2004-06-08;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
APOTEX INC
DIN: 02254522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73942
PRO-QUININE – 300;
quinine sulfate 300 mg;
2008-07-03;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
PRO DOC LIMITEE
DIN: 02311224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79681
JAMP-QUININE;
quinine sulfate 300 mg;
2015-09-16;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02445204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93043
PARIET, ENTERIC-COATED TABLET 10MG;
rabeprazole sodium 10 mg;
2002-04-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JANSSEN INC
DIN: 02243796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67734
TEVA-RABEPRAZOLE EC;
rabeprazole sodium 10 mg;
2007-11-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02296632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78199
TARO-RABEPRAZOLE;
rabeprazole sodium 10 mg;
2007-11-09;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02298074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78338
PMS-RABEPRAZOLE EC;
rabeprazole sodium 10 mg;
2008-06-03;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02310805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79643
SANDOZ RABEPRAZOLE;
rabeprazole sodium 10 mg;
2008-07-29;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02314177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79974
PRO-RABEPRAZOLE;
rabeprazole sodium 10 mg;
2009-02-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02315181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80074
RABEPRAZOLE EC;
rabeprazole sodium 10 mg;
2010-11-23;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02356511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84166
RABEPRAZOLE;
rabeprazole sodium 10 mg;
2012-06-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87107
PARIET, ENTERIC-COATED TABLET 20MG;
rabeprazole sodium 20 mg;
2002-04-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JANSSEN INC
DIN: 02243797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67735
TEVA-RABEPRAZOLE EC;
rabeprazole sodium 20 mg;
2007-11-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02296640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78200
TARO-RABEPRAZOLE;
rabeprazole sodium 20 mg;
2007-11-09;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02298082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78339
PMS-RABEPRAZOLE EC;
rabeprazole sodium 20 mg;
2008-06-03;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02310813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79644
SANDOZ RABEPRAZOLE;
rabeprazole sodium 20 mg;
2008-07-29;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02314185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79975
RABEPRAZOLE EC;
rabeprazole sodium 20 mg;
2010-11-23;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02356538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84167
RABEPRAZOLE;
rabeprazole sodium 20 mg;
2012-06-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87108
IMOGAM RABIES PASTEURIZED;
rabies immunoglobulin (human) 150 unit / ml;
1999-04-30;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02237328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60651
KAMRAB;
rabies immunoglobulin (human) 150 unit / ml;
2020-04-06;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
KAMADA LTD
DIN: 02482436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97288
HYPERRAB;
rabies immunoglobulin (human) 300 unit / ml;
2019-07-02;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02486571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97677
IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO);
rabies vaccine inactivated (human diploid-cell culture) 2.5 unit / vial;
1999-08-13;
Intramuscular;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 01908286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46832
RABAVERT;
rabies vaccine inactivated (purified chick embryo cell culture) 2.5 unit / dose;
2005-05-16;
Intramuscular;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
BAVARIAN NORDIC AS
DIN: 02267667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75308
EVISTA (60MG);
raloxifene hydrochloride 60 mg;
1998-11-20;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
ELI LILLY CANADA INC
DIN: 02239028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62480
APO-RALOXIFENE;
raloxifene hydrochloride 60 mg;
2009-03-31;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02279215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76475
ACT RALOXIFENE;
raloxifene hydrochloride 60 mg;
2012-06-19;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02358840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84388
ISENTRESS;
raltegravir (raltegravir potassium) 100 mg;
2013-02-11;
Oral;
Tablet (Chewable);
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02392437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87771
ISENTRESS;
raltegravir (raltegravir potassium) 25 mg;
2013-02-11;
Oral;
Tablet (Chewable);
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02392429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87770
ISENTRESS;
raltegravir (raltegravir potassium) 400 mg;
2007-11-28;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02301881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78722
ISENTRESS HD;
raltegravir (raltegravir potassium) 600 mg;
2017-09-11;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02465337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95353
TOMUDEX;
raltitrexed (raltitrexed disodium) 2 mg / vial;
1996-11-18;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02229566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47482
ALTACE;
ramipril 1.25 mg;
1997-05-28;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02221829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43308
APO-RAMIPRIL;
ramipril 1.25 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02251515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73644
RAMIPRIL;
ramipril 1.25 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02308363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79402
PRO-RAMIPRIL – 1.25;
ramipril 1.25 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79569
TARO-RAMIPRIL;
ramipril 1.25 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02310503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79613
AURO-RAMIPRIL;
ramipril 1.25 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02387387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87297
PHARMA-RAMIPRIL;
ramipril 1.25 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95770
ALTACE;
ramipril 10 mg;
1997-03-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02221853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43311
TEVA-RAMIPRIL;
ramipril 10 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72257
APO-RAMIPRIL;
ramipril 10 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02251582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73650
RAMIPRIL;
ramipril 10 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02255332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74051
RAMIPRIL;
ramipril 10 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02287943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77335
PRO-RAMIPRIL – 10;
ramipril 10 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79575
TARO-RAMIPRIL;
ramipril 10 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02310546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79616
JAMP-RAMIPRIL;
ramipril 10 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02331144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81686
RAMIPRIL;
ramipril 10 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02374862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86021
AURO-RAMIPRIL;
ramipril 10 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02387417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87300
MAR-RAMIPRIL;
ramipril 10 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02420481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90507
MINT-RAMIPRIL;
ramipril 10 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90596
PHARMA-RAMIPRIL;
ramipril 10 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95773
AG-RAMIPRIL;
ramipril 10 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96786
PRIVA-RAMIPRIL;
ramipril 10 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97259
NRA-RAMIPRIL;
ramipril 10 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02486199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97642
RAMIPRIL;
ramipril 10 mg;
2020-02-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02486539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97673
ALTACE;
ramipril 15 mg;
2006-08-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02281112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76678
APO-RAMIPRIL;
ramipril 15 mg;
2009-05-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02325381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81078
MAR-RAMIPRIL;
ramipril 15 mg;
2014-09-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02420503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90508
MINT-RAMIPRIL;
ramipril 15 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90597
JAMP-RAMIPRIL;
ramipril 15 mg;
2015-09-08;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02440334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92469
ALTACE;
ramipril 2.5 mg;
1997-04-21;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02221837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43309
TEVA-RAMIPRIL;
ramipril 2.5 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72255
APO-RAMIPRIL;
ramipril 2.5 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02251531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73646
RAMIPRIL;
ramipril 2.5 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02255316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74047
RAMIPRIL;
ramipril 2.5 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02287927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77332
PRO-RAMIPRIL – 2.5;
ramipril 2.5 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79571
TARO-RAMIPRIL;
ramipril 2.5 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02310511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79614
JAMP-RAMIPRIL;
ramipril 2.5 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02331128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81684
RAMIPRIL;
ramipril 2.5 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02374846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86019
AURO-RAMIPRIL;
ramipril 2.5 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02387395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87298
MAR-RAMIPRIL;
ramipril 2.5 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02420465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90505
MINT-RAMIPRIL;
ramipril 2.5 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90594
PHARMA-RAMIPRIL;
ramipril 2.5 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95771
AG-RAMIPRIL;
ramipril 2.5 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96784
PRIVA-RAMIPRIL;
ramipril 2.5 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97257
NRA-RAMIPRIL;
ramipril 2.5 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02486172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97640
RAMIPRIL;
ramipril 2.5 mg;
2020-03-19;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02486512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97671
ALTACE;
ramipril 5 mg;
1997-04-21;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02221845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43310
TEVA-RAMIPRIL;
ramipril 5 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02247946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72256
APO-RAMIPRIL;
ramipril 5 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02251574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73648
RAMIPRIL;
ramipril 5 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02255324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74048
RAMIPRIL;
ramipril 5 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02287935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77334
PRO-RAMIPRIL – 5;
ramipril 5 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79574
TARO-RAMIPRIL;
ramipril 5 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02310538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79615
JAMP-RAMIPRIL;
ramipril 5 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02331136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81685
RAMIPRIL;
ramipril 5 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02374854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86020
AURO-RAMIPRIL;
ramipril 5 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02387409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87299
MAR-RAMIPRIL;
ramipril 5 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02420473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90506
MINT-RAMIPRIL;
ramipril 5 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02421313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90595
PHARMA-RAMIPRIL;
ramipril 5 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95772
AG-RAMIPRIL;
ramipril 5 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96785
PRIVA-RAMIPRIL;
ramipril 5 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02483424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97258
NRA-RAMIPRIL;
ramipril 5 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02486180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97641
RAMIPRIL;
ramipril 5 mg;
2020-02-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
DIN: 02486520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97672
CYRAMZA;
ramucirumab 10 mg / ml;
2015-09-10;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02443805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92855
LUCENTIS;
ranibizumab 10 mg / ml;
2007-07-26;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02296810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78217
LUCENTIS;
ranibizumab 10 mg / ml;
2014-09-18;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02425629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91026
PMS-RANITIDINE 150 MG;
ranitidine (ranitidine hydrochloride) 150 mg;
2000-08-25;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02242453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66172
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION;
ranitidine (ranitidine hydrochloride) 150 mg;
2007-07-18;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
PHARMASCIENCE INC
DIN: 02293471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77884
RAN-RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2009-11-02;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02336480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82205
RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2010-07-26;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02353016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83824
MAR-RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-11-09;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02443708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92844
JAMP-RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-10-24;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02463717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95181
M-RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-12-11;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MANTRA PHARMA INC
DIN: 02473534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96292
AG-RANITIDINE;
ranitidine (ranitidine hydrochloride) 150 mg;
2019-08-14;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02484501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97481
PMS-RANITIDINE 300 MG;
ranitidine (ranitidine hydrochloride) 300 mg;
2000-08-25;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02242454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66173
RAN-RANITIDINE;
ranitidine (ranitidine hydrochloride) 300 mg;
2009-11-02;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02336502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82207
RANITIDINE;
ranitidine (ranitidine hydrochloride) 300 mg;
2010-07-26;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02353024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83825
MAR-RANITIDINE;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-11-09;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02443716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92845
JAMP-RANITIDINE;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-10-24;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02463725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95182
M-RANITIDINE;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-12-11;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MANTRA PHARMA INC
DIN: 02473542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96293
ACID REDUCER;
ranitidine (ranitidine hydrochloride) 75 mg;
2004-07-13;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
PHARMASCIENCE INC
DIN: 02247551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71801
CORZYNA;
ranolazine 500 mg;
2021-05-03;
Oral;
Tablet (Extended-Release);
24:04.92 – MISCELLANEOUS CARDIAC DRUGS;
Prescription;
KYE PHARMACEUTICALS INC.
DIN: 02510219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99945
AZILECT;
rasagiline (rasagiline mesylate) 0.5 mg;
2006-09-14;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77019
APO-RASAGILINE;
rasagiline (rasagiline mesylate) 0.5 mg;
2016-01-12;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
APOTEX INC
DIN: 02404680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88948
TEVA-RASAGILINE;
rasagiline (rasagiline mesylate) 0.5 mg;
2016-05-30;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02418436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90300
JAMP RASAGILINE;
rasagiline (rasagiline mesylate) 0.5 mg;
2020-09-04;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02491974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98198
AZILECT;
rasagiline (rasagiline mesylate) 1 mg;
2006-09-14;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02284650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77020
APO-RASAGILINE;
rasagiline (rasagiline mesylate) 1 mg;
2016-01-12;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
APOTEX INC
DIN: 02404699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88949
TEVA-RASAGILINE;
rasagiline (rasagiline mesylate) 1 mg;
2016-05-30;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02418444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90301
JAMP RASAGILINE;
rasagiline (rasagiline mesylate) 1 mg;
2020-09-04;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02491982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98199
FASTURTEC;
rasburicase 1.5 mg / vial;
2004-09-21;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02248416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72766
ALPROLIX;
recombinant human coagulation factor ix – fc fusion protein 1000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02422921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90758
ALPROLIX;
recombinant human coagulation factor ix – fc fusion protein 2000 unit / vial;
2015-12-11;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02422948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90759
ALPROLIX;
recombinant human coagulation factor ix – fc fusion protein 3000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02422956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90760
ALPROLIX;
recombinant human coagulation factor ix – fc fusion protein 500 unit / vial;
2015-12-11;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02422913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90757
STIVARGA;
regorafenib 40 mg;
2013-04-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
DIN: 02403390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88820
VEKLURY;
remdesivir 100 mg / vial;
2020-10-16;
Intravenous;
Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02502143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99173
REMIFENTANIL FOR INJECTION;
remifentanil (remifentanil hydrochloride) 1 mg / vial;
2014-06-05;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02344424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82993
REMIFENTANIL HYDROCHLORIDE FOR INJECTION;
remifentanil (remifentanil hydrochloride) 1 mg / vial;
2011-09-27;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02366460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85131
REMIFENTANIL FOR INJECTION;
remifentanil (remifentanil hydrochloride) 2 mg / vial;
2014-06-05;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02344432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82994
REMIFENTANIL HYDROCHLORIDE FOR INJECTION;
remifentanil (remifentanil hydrochloride) 2 mg / vial;
2011-09-29;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02366479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85132
GLUCONORM 0.5MG;
repaglinide 0.5 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
DIN: 02239924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63424
ACT REPAGLINIDE;
repaglinide 0.5 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02321475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80688
SANDOZ REPAGLINIDE;
repaglinide 0.5 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02357453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84259
REPAGLINIDE;
repaglinide 0.5 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02415968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90056
AURO-REPAGLINIDE;
repaglinide 0.5 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
DIN: 02424258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90896
GLUCONORM 1.0MG;
repaglinide 1 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
DIN: 02239925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63425
ACT REPAGLINIDE;
repaglinide 1 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02321483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80689
SANDOZ REPAGLINIDE;
repaglinide 1 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02357461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84260
REPAGLINIDE;
repaglinide 1 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02415976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90057
AURO-REPAGLINIDE;
repaglinide 1 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
DIN: 02424266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90897
GLUCONORM 2.0MG;
repaglinide 2 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
DIN: 02239926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63426
ACT REPAGLINIDE;
repaglinide 2 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02321491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80690
SANDOZ REPAGLINIDE;
repaglinide 2 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02357488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84261
REPAGLINIDE;
repaglinide 2 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02415984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90058
AURO-REPAGLINIDE;
repaglinide 2 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
DIN: 02424274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90898
CINQAIR;
reslizumab 10 mg / ml;
2016-12-19;
Intravenous;
Solution;
48:10.20 – INTERLEUKIN ANTAGONISTS;
Prescription , Schedule D;
TEVA CANADA LIMITED
DIN: 02456419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94330
IBAVYR;
ribavirin 200 mg;
2015-05-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02439212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92360
IBAVYR;
ribavirin 400 mg;
2014-07-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02425890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91049
VIRAZOLE;
ribavirin 6 g / vial;
1996-12-05;
Inhalation;
Aerosol , Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02170140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34574
KISQALI;
ribociclib (ribociclib succinate) 200 mg;
2018-04-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02473569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96295
MYCOBUTIN;
rifabutin 150 mg;
1995-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02063786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18081
ROFACT;
rifampin 150 mg;
1977-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00393444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2866
ROFACT;
rifampin 300 mg;
1977-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00343617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2863
ZAXINE;
rifaximin 550 mg;
2013-11-07;
Oral;
Tablet;
08:12.28.30 – RIFAMYCINS;
Prescription;
SALIX PHARMACEUTICALS INC
DIN: 02410702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89537
EDURANT;
rilpivirine (rilpivirine hydrochloride) 25 mg;
2011-08-31;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JANSSEN INC
DIN: 02370603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85574
RILUTEK;
riluzole 50 mg;
2000-10-26;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02242763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66576
APO-RILUZOLE;
riluzole 50 mg;
2012-09-25;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
DIN: 02352583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83784
MYLAN-RILUZOLE;
riluzole 50 mg;
2012-10-23;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02390299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87574
ADEMPAS;
riociguat 0.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
DIN: 02412764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89742
ADEMPAS;
riociguat 1 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
DIN: 02412772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89743
ADEMPAS;
riociguat 1.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
DIN: 02412799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89745
ADEMPAS;
riociguat 2 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
DIN: 02412802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89746
ADEMPAS;
riociguat 2.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
DIN: 02412810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89747
QINLOCK;
ripretinib 50 mg;
2020-12-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DECIPHERA PHARMACEUTICALS. LLC
DIN: 02500833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99049
SKYRIZI;
risankizumab 90 mg / 1 ml;
2019-05-13;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
ABBVIE CORPORATION
DIN: 02487454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97761
EVRYSDI;
risdiplam 0.75 mg / ml;
2021-05-19;
Oral;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription Recommended;
HOFFMANN-LA ROCHE LIMITED
DIN: 02514931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100434
ACTONEL;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2008-12-01;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
DIN: 02316838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80233
APO-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2012-05-17;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
DIN: 02377721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86354
PMS-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2014-05-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02424177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90889
ACTONEL;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2002-12-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
DIN: 02246896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71123
PMS-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02302209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78754
SANDOZ RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81259
RIVA-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02341077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82662
RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-10-15;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02347474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83286
APO-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-11-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
DIN: 02353687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83888
JAMP-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2011-10-04;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85353
ACTONEL DR;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2011-08-10;
Oral;
Tablet (Delayed-Release);
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
DIN: 02370417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85557
AURO-RISEDRONATE;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2013-07-08;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02406306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89102
APO-RISEDRONATE DR;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2021-05-18;
Oral;
Tablet (Delayed-Release);
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
DIN: 02493268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98324
TEVA-RISEDRONATE;
risedronate sodium (risedronate sodium monohydrate) 150 mg;
2013-10-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02413809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89845
TEVA-RISEDRONATE;
risedronate sodium (risedronate sodium monohydrate) 30 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02298384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78368
TEVA-RISEDRONATE;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02298392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78369
RISEDRONATE;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2011-10-18;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02370255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85541
RISEDRONATE-35;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2013-10-23;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89602
TEVA-RISEDRONATE;
risedronate sodium (risedronate sodium monohydrate) 5 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02298376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78367
RISPERDAL ORAL SOLUTION;
risperidone (risperidone tartrate) 1 mg / ml;
1998-03-04;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02236950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60243
PMS-RISPERIDONE;
risperidone (risperidone tartrate) 1 mg / ml;
2006-07-05;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02279266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76481
APO-RISPERIDONE;
risperidone (risperidone tartrate) 1 mg / ml;
2006-07-05;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02280396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76606
JAMP-RISPERIDONE;
risperidone (risperidone tartrate) 1 mg / ml;
2018-08-22;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02454319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94083
PMS-RISPERIDONE;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73690
APO-RISPERIDONE;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76778
TEVA-RISPERIDONE;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02282690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76833
RIVA-RISPERIDONE;
risperidone 0.25 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76916
SANDOZ RISPERIDONE;
risperidone 0.25 mg;
2007-12-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02303655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78897
PRO-RISPERIDONE;
risperidone 0.25 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79823
RAN-RISPERIDONE;
risperidone 0.25 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81383
RISPERIDONE;
risperidone 0.25 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84200
JAMP-RISPERIDONE;
risperidone 0.25 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84454
MINT-RISPERIDON;
risperidone 0.25 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84478
AG-RISPERIDONE;
risperidone 0.25 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85402
MAR-RISPERIDONE;
risperidone 0.25 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85689
PMS-RISPERIDONE;
risperidone 0.5 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73691
APO-RISPERIDONE;
risperidone 0.5 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76779
RIVA-RISPERIDONE;
risperidone 0.5 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76917
SANDOZ RISPERIDONE;
risperidone 0.5 mg;
2007-12-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02303663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78898
PRO-RISPERIDONE;
risperidone 0.5 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79824
RAN-RISPERIDONE;
risperidone 0.5 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81384
RISPERIDONE;
risperidone 0.5 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84201
JAMP-RISPERIDONE;
risperidone 0.5 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84455
MINT-RISPERIDON;
risperidone 0.5 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84479
AG-RISPERIDONE;
risperidone 0.5 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85403
MAR-RISPERIDONE;
risperidone 0.5 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85690
PMS-RISPERIDONE;
risperidone 1 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73692
TEVA-RISPERIDONE;
risperidone 1 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02264196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74963
SANDOZ RISPERIDONE;
risperidone 1 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76539
APO-RISPERIDONE;
risperidone 1 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76780
RIVA-RISPERIDONE;
risperidone 1 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76918
PRO-RISPERIDONE;
risperidone 1 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79825
RAN-RISPERIDONE;
risperidone 1 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81385
RISPERIDONE;
risperidone 1 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84202
JAMP-RISPERIDONE;
risperidone 1 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84456
MINT-RISPERIDON;
risperidone 1 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84480
AG-RISPERIDONE;
risperidone 1 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85404
MAR-RISPERIDONE;
risperidone 1 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85691
RISPERDAL CONSTA;
risperidone 12.5 mg / vial;
2007-10-24;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02298465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78377
PERSERIS;
risperidone 120 mg / syr;
2021-06-15;
Subcutaneous;
Powder For Suspension , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
DIN: 02507846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99722
PMS-RISPERIDONE;
risperidone 2 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73693
TEVA-RISPERIDONE;
risperidone 2 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02264218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74964
SANDOZ RISPERIDONE;
risperidone 2 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76540
APO-RISPERIDONE;
risperidone 2 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76781
RIVA-RISPERIDONE;
risperidone 2 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76919
PRO-RISPERIDONE;
risperidone 2 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79826
RAN-RISPERIDONE;
risperidone 2 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81386
RISPERIDONE;
risperidone 2 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84203
JAMP-RISPERIDONE;
risperidone 2 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84457
MINT-RISPERIDON;
risperidone 2 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84481
AG-RISPERIDONE;
risperidone 2 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85406
MAR-RISPERIDONE;
risperidone 2 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85692
RISPERDAL CONSTA;
risperidone 25 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02255707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74089
PMS-RISPERIDONE;
risperidone 3 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73694
TEVA-RISPERIDONE;
risperidone 3 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02264226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74965
SANDOZ RISPERIDONE;
risperidone 3 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76541
APO-RISPERIDONE;
risperidone 3 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76782
RIVA-RISPERIDONE;
risperidone 3 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76920
PRO-RISPERIDONE;
risperidone 3 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79827
RAN-RISPERIDONE;
risperidone 3 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328364
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81388
RISPERIDONE;
risperidone 3 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84204
JAMP-RISPERIDONE;
risperidone 3 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84458
MINT-RISPERIDON;
risperidone 3 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84482
AG-RISPERIDONE;
risperidone 3 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85407
MAR-RISPERIDONE;
risperidone 3 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85693
RISPERDAL CONSTA;
risperidone 37.5 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02255723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74091
PMS-RISPERIDONE;
risperidone 4 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02252066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73695
TEVA-RISPERIDONE;
risperidone 4 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02264234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74966
SANDOZ RISPERIDONE;
risperidone 4 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02279835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76542
APO-RISPERIDONE;
risperidone 4 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
DIN: 02282178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76783
RIVA-RISPERIDONE;
risperidone 4 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02283638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76921
PRO-RISPERIDONE;
risperidone 4 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02312751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79828
RAN-RISPERIDONE;
risperidone 4 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02328372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81389
RISPERIDONE;
risperidone 4 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02356937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84205
JAMP-RISPERIDONE;
risperidone 4 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02359588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84459
MINT-RISPERIDON;
risperidone 4 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02359847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84483
AG-RISPERIDONE;
risperidone 4 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02369133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85408
MAR-RISPERIDONE;
risperidone 4 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02371812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85694
RISPERDAL CONSTA;
risperidone 50 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
DIN: 02255758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74093
PERSERIS;
risperidone 90 mg / syr;
2021-06-15;
Subcutaneous;
Powder For Suspension , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
DIN: 02507838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99721
NORVIR;
ritonavir 100 mg;
2010-12-17;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
DIN: 02357593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84270
RITUXAN;
rituximab 10 mg / ml;
2000-03-20;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02241927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65597
RUXIENCE;
rituximab 10 mg / ml;
2020-05-26;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02495724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98562
RIXIMYO;
rituximab 10 mg / ml;
2020-05-22;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Schedule D;
SANDOZ CANADA INCORPORATED
DIN: 02498316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98809
RIABNI;
rituximab 10 mg / ml;
2021-04-21;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02513447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100265
TRUXIMA;
rituximab 100 mg / 10 ml;
2019-12-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02478382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96914
RITUXAN SC;
rituximab 1400 mg / 11.7 ml;
2016-11-22;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02457350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94441
RITUXAN SC;
rituximab 1600 mg / 13.4 ml;
2018-04-24;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02473976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96398
TRUXIMA;
rituximab 500 mg / 50 ml;
2019-12-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02478390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96915
XARELTO;
rivaroxaban 10 mg;
2008-09-16;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02316986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80247
XARELTO;
rivaroxaban 103.4 mg / bottle;
2021-06-11;
Oral;
Granules For Suspension;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02510170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99941
XARELTO;
rivaroxaban 15 mg;
2012-01-17;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02378604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86439
XARELTO;
rivaroxaban 2.5 mg;
2018-09-28;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02480808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97146
XARELTO;
rivaroxaban 20 mg;
2012-01-17;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02378612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86440
XARELTO;
rivaroxaban 51.7 mg / bottle;
2021-06-11;
Oral;
Granules For Suspension;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
DIN: 02510162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99940
EXELON 1.5 MG;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65791
SANDOZ RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02324563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81001
APO-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
DIN: 02336715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82234
MED-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02401614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88650
RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02416999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90163
JAMP RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02485362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97561
EXELON;
rivastigmine (rivastigmine hydrogen tartrate) 2 mg / ml;
2002-12-05;
Oral;
Solution;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02245240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69257
EXELON;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65792
SANDOZ RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02324571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81002
APO-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
DIN: 02336723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82235
MED-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02401622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88651
RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02417006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90164
JAMP RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02485370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97562
EXELON;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65793
SANDOZ RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02324598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81003
APO-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
DIN: 02336731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82236
MED-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2014-11-12;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02401630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88652
RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02417014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90165
JAMP RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02485389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97563
EXELON;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02242118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65794
SANDOZ RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02324601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81004
APO-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
DIN: 02336758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82237
MED-RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02401649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88653
RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02417022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90166
JAMP RIVASTIGMINE;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02485397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97564
EXELON PATCH 15;
rivastigmine 13.3 mg / 24 hour;
2015-04-17;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02432803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91722
RIVASTIGMINE PATCH 15;
rivastigmine 13.3 mg / 24 hour;
2021-04-15;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02479567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97023
EXELON PATCH 5;
rivastigmine 4.6 mg / 24 hour;
2007-12-12;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02302845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78816
MYLAN-RIVASTIGMINE PATCH 5;
rivastigmine 4.6 mg / 24 hour;
2016-12-05;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02423413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90814
SANDOZ RIVASTIGMINE PATCH 5;
rivastigmine 4.6 mg / 24 hour;
2016-11-30;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02426293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91089
RIVASTIGMINE PATCH 5;
rivastigmine 4.6 mg / 24 hour;
2021-04-15;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02479540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97021
EXELON PATCH 10;
rivastigmine 9.5 mg / 24 hour;
2007-12-12;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02302853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78817
MYLAN-RIVASTIGMINE PATCH 10;
rivastigmine 9.5 mg / 24 hour;
2016-12-05;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02423421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90815
SANDOZ RIVASTIGMINE PATCH 10;
rivastigmine 9.5 mg / 24 hour;
2016-11-30;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02426307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91090
RIVASTIGMINE PATCH 10;
rivastigmine 9.5 mg / 24 hour;
2021-04-15;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02479559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97022
MAXALT RPD;
rizatriptan (rizatriptan benzoate) 10 mg;
1999-08-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02240519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64090
MAXALT;
rizatriptan (rizatriptan benzoate) 10 mg;
1999-08-31;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02240521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64092
SANDOZ RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-01-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02351889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83712
MYLAN-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-01-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02379201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86509
MAR-RIZATRIPTAN;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-05-03;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02379678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86554
JAMP-RIZATRIPTAN;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-03-26;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02380463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86627
ACT RIZATRIPTAN;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-06-14;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02381702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86756
PMS-RIZATRIPTAN RDT;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-10-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02393379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87860
APO-RIZATRIPTAN;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-09-27;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
DIN: 02393476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87869
TEVA-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2014-11-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02396688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88171
RIZATRIPTAN RDT;
rizatriptan (rizatriptan benzoate) 10 mg;
2013-11-28;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02415801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90040
JAMP-RIZATRIPTAN IR;
rizatriptan (rizatriptan benzoate) 10 mg;
2014-09-25;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02429241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91368
NAT-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-02-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02436612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92094
RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-07-23;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02442914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92742
RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02446138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93139
CCP-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2019-01-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02458772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94592
MAR-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2018-02-15;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02462796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95063
JAMP-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2018-02-12;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02465094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95328
ACCEL-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2019-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ACCEL PHARMA INC
DIN: 02483289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97372
NRA-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2020-01-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NORA PHARMA INC
DIN: 02489384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97947
AG-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 10 mg;
2020-01-27;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02492490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98250
MAXALT RPD;
rizatriptan (rizatriptan benzoate) 5 mg;
2000-05-05;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02240518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64089
SANDOZ RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-01-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02351870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83711
MYLAN-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-01-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02379198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86508
PMS-RIZATRIPTAN RDT;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-10-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02393360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87859
APO-RIZATRIPTAN;
rizatriptan (rizatriptan benzoate) 5 mg;
2013-03-06;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
DIN: 02393468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87868
TEVA-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2014-11-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02396661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88170
RIZATRIPTAN RDT;
rizatriptan (rizatriptan benzoate) 5 mg;
2013-11-28;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02415798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90039
JAMP-RIZATRIPTAN IR;
rizatriptan (rizatriptan benzoate) 5 mg;
2014-09-25;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02429233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91367
NAT-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-02-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02436604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92093
RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-07-23;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02442906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92741
RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02446111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93138
CCP-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2019-01-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02458764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94591
MAR-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2018-02-15;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02462788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95062
JAMP-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2018-02-12;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02465086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95327
ACCEL-RIZATRIPTAN ODT;
rizatriptan (rizatriptan benzoate) 5 mg;
2019-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ACCEL PHARMA INC
DIN: 02483270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97371
ROCURONIUM BROMIDE INJECTION;
rocuronium bromide 10 mg / ml;
2009-02-10;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02318121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80363
ROCURONIUM BROMIDE INJECTION;
rocuronium bromide 10 mg / ml;
2008-10-24;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02318415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80390
ROCURONIUM BROMIDE INJECTION;
rocuronium bromide 10 mg / ml;
2019-01-17;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
DIN: 02469774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95863
ROCURONIUM BROMIDE INJECTION;
rocuronium bromide 10 mg / ml;
2020-11-24;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
DIN: 02498820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98856
DAXAS;
roflumilast 500 mcg;
2010-12-30;
Oral;
Tablet;
48:32.00 – Phosphodiesterase Type 4 Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02359456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84447
ISTODAX;
romidepsin 10 mg / vial;
2014-02-05;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02414295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89895
NPLATE;
romiplostim 250 mcg / vial;
2009-04-15;
Subcutaneous;
Powder For Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02322854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80832
NPLATE;
romiplostim 500 mcg / vial;
2009-04-15;
Subcutaneous;
Powder For Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02322862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80833
EVENITY;
romosozumab 105 mg / 1.17 ml;
2019-08-12;
Subcutaneous;
Solution;
92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02489597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97967
RAN-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02314037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79955
TEVA-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80234
JAMP-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02352338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83760
ROPINIROLE;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2010-07-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02353040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83827
RAN-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 1 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02314053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79957
TEVA-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 1 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80235
JAMP-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 1 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02352346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83761
ROPINIROLE;
ropinirole (ropinirole hydrochloride) 1 mg;
2010-07-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02353059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83828
RAN-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 2 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02314061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79958
TEVA-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 2 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80236
JAMP-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 2 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02352354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83762
RAN-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 5 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02314088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79959
TEVA-ROPINIROLE;
ropinirole (ropinirole hydrochloride) 5 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80237
NAROPIN;
ropivacaine hydrochloride 10 mg / ml;
1997-04-30;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02229418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47225
ROPIVACAINE HYDROCHLORIDE INJECTION USP;
ropivacaine hydrochloride 10 mg / ml;
2010-12-14;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02347830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83320
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
ropivacaine hydrochloride 10 mg / ml;
2019-02-26;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02439409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92377
NAROPIN;
ropivacaine hydrochloride 2 mg / ml;
1997-04-30;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02229411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47216
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
ropivacaine hydrochloride 2 mg / ml;
2018-09-28;
Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02439379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92374
NAROPIN;
ropivacaine hydrochloride 5 mg / ml;
1997-04-30;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02229415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47220
ROPIVACAINE HYDROCHLORIDE INJECTION USP;
ropivacaine hydrochloride 5 mg / ml;
2010-12-14;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02347822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83319
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
ropivacaine hydrochloride 5 mg / ml;
2019-09-13;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02439387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92375
ROSIGLITAZONE;
rosiglitazone (rosiglitazone maleate) 2 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
DIN: 02403366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88817
ROSIGLITAZONE;
rosiglitazone (rosiglitazone maleate) 4 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
DIN: 02403374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88818
ROSIGLITAZONE;
rosiglitazone (rosiglitazone maleate) 8 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
DIN: 02403382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88819
CRESTOR – 10MG;
rosuvastatin (rosuvastatin calcium) 10 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02247162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71404
APO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02337983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82363
SANDOZ ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02338734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82438
TEVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02354616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83978
PMS-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02378531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86433
RIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02380056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86589
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02381184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86696
TARO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02382652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86847
JAMP-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02391260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87661
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02405636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89040
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89623
ACH-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92330
AURO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02442582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92692
BIO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93019
PRIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93065
AG-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96734
NRA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02477491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96855
M-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 10 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02496542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98640
JAMP ROSUVASTATIN CALCIUM;
rosuvastatin (rosuvastatin calcium) 10 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02498340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98812
CRESTOR – 20MG;
rosuvastatin (rosuvastatin calcium) 20 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02247163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71405
APO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02337991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82364
SANDOZ ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02338742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82439
TEVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02354624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83979
PMS-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02378558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86434
RIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02380064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86590
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02381192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86697
TARO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02382660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86848
JAMP-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02391279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87662
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02405644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89041
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89624
ACH-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92331
AURO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02442590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92693
BIO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93020
PRIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93066
AG-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96735
NRA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02477505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96856
M-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 20 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02496550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98641
JAMP ROSUVASTATIN CALCIUM;
rosuvastatin (rosuvastatin calcium) 20 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02498359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98813
CRESTOR – 40MG;
rosuvastatin (rosuvastatin calcium) 40 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02247164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71406
APO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02338009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82365
SANDOZ ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02338750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82440
TEVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02354632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83980
PMS-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02378566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86435
RIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02380102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86594
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02381206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86698
TARO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02382679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86849
JAMP-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02391287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87663
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02405652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89042
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89625
ACH-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92332
AURO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02442604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92694
BIO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93021
AG-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96736
M-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 40 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02496569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98642
JAMP ROSUVASTATIN CALCIUM;
rosuvastatin (rosuvastatin calcium) 40 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02498367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98814
CRESTOR – 5MG;
rosuvastatin (rosuvastatin calcium) 5 mg;
2005-03-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02265540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75100
APO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02337975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82362
SANDOZ ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02338726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82437
TEVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02354608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83977
PMS-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02378523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86432
RIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02380013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86586
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02381176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86695
TARO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02382644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86846
JAMP-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02391252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87660
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02405628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89039
ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02411628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89622
ACH-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92329
AURO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02442574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92691
BIO-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02444968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93018
PRIVA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93064
AG-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96733
NRA-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02477483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96854
M-ROSUVASTATIN;
rosuvastatin (rosuvastatin calcium) 5 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02496534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98639
JAMP ROSUVASTATIN CALCIUM;
rosuvastatin (rosuvastatin calcium) 5 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02498332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98811
ROTARIX;
rotavirus vaccine (rix4414 strain) – live – oral – attenuated (human) 1000000 ccid50 / 1.5 ml;
2008-12-16;
Oral;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02300591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78588
NEUPRO;
rotigotine 1 mg / 24 hour;
2013-12-19;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88866
NEUPRO;
rotigotine 2 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88867
NEUPRO;
rotigotine 3 mg / 24 hour;
2013-12-19;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88868
NEUPRO;
rotigotine 4 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88869
NEUPRO;
rotigotine 6 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88870
NEUPRO;
rotigotine 8 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
DIN: 02403943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88871
BANZEL;
rufinamide 100 mg;
2011-10-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02369613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85454
BANZEL;
rufinamide 200 mg;
2011-08-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02369621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85455
BANZEL;
rufinamide 400 mg;
2011-09-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
DIN: 02369648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85456
RUPALL;
rupatadine (rupatadine fumarate) 1 mg / ml;
2017-01-20;
Oral;
Solution;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MEDEXUS PHARMACEUTICALS INC
DIN: 02456478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94336
RUPALL;
rupatadine (rupatadine fumarate) 10 mg;
2017-01-16;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MEDEXUS PHARMACEUTICALS INC
DIN: 02456451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94335
JAKAVI;
ruxolitinib (ruxolitinib phosphate) 10 mg;
2015-04-15;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02434814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91911
JAKAVI;
ruxolitinib (ruxolitinib phosphate) 15 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02388014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87358
JAKAVI;
ruxolitinib (ruxolitinib phosphate) 20 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02388022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87359
JAKAVI;
ruxolitinib (ruxolitinib phosphate) 5 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02388006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87357
JAKAVI;
02388014;
ruxolitinib (ruxolitinib phosphate) 15 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87358
JAKAVI;
02388022;
ruxolitinib (ruxolitinib phosphate) 20 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87359
JAKAVI;
02388006;
ruxolitinib (ruxolitinib phosphate) 5 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87357

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut